Author: "ESC Committee, for Practice Guidelines" - Searchworks@Jio Institute Digital Library Search Results

Your search keyword '"ESC Committee, for Practice Guidelines"' showing total 38 results

Start Over Author "ESC Committee, for Practice Guidelines"

38 results on '"ESC Committee, for Practice Guidelines"'

1. Corrigendum to '2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk' [Atherosclerosis 290 (2019) 140-205]

Author: Task Force Members, ESC National Cardiac Societies, ESC Committee for Practice Guidelines (CPG), and University of Zurich
Subjects: 10265 Clinic for Endocrinology and Diabetology, 610 Medicine & health, 2705 Cardiology and Cardiovascular Medicine
Published: 2020
Full Text: View/download PDF

2. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes

Author: Task Force, European Society of Cardiology (ESC), and ESC Committee for Practice Guidelines (CPG)
Subjects: Anti-ischaemic drugs, Antithrombotic therapy, Lipid-lowering drugs, Angina pectoris, Chronic coronary syndromes, Guidelines, Myocardial ischaemia, Coronary artery disease, Lifestyle modifications, Vasospastic angina, Imaging, Diagnostic testing, Microvascular angina, Myocardial revascularization, Screening, Journal Article, Cardiology and Cardiovascular Medicine, Risk assessment
Abstract: Coronary artery disease (CAD) is a pathological process characterized by atherosclerotic plaque accumulation in the epicardial arteries, whether obstructive or non-obstructive. This process can be modified by lifestyle adjustments, pharmacological therapies, and invasive interventions designed to achieve disease stabilization or regression. The disease can have long, stable periods but can also become unstable at any time, typically due to an acute atherothrombotic event caused by plaque rupture or erosion. However, the disease is chronic, most often progressive, and hence serious, even in clinically apparently silent periods. The dynamic nature of the CAD process results in various clinical presentations, which can be conveniently categorized as either acute coronary syndromes (ACS) or chronic coronary syndromes (CCS). The Guidelines presented here refer to the management of patients with CCS. The natural history of CCS is illustrated in Figure 1.
Published: 2020

3. 2019 ESC/EAS guidelines for the management of dyslipidaemias : Lipid modification to reduce cardiovascular risk

Author: Authors/Task Force Members, ESC Committee for Practice Guidelines (CPG), ESC National Cardiac Societies, and University of Zurich
Subjects: Treatment (drugs), Very low-density lipoproteins, 10265 Clinic for Endocrinology and Diabetology, 610 Medicine & health, Lipoprotein remnants, Guidelines, Total cardiovascular risk, 2705 Cardiology and Cardiovascular Medicine, Treatment (lifestyle), Treatment (adherence), Journal Article, Low-density lipoproteins, High-density lipoproteins, Cholesterol, Familial hypercholesterolaemia, Cardiology and Cardiovascular Medicine, Apolipoprotein B, Dyslipidaemias, Triglycerides, Lipoprotein(a)
Published: 2019

4. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes

Author: Global Health, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, Cardiovasculaire Epi Team 9, Task Force, European Society of Cardiology (ESC), ESC Committee for Practice Guidelines (CPG), Global Health, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, Cardiovasculaire Epi Team 9, Task Force, European Society of Cardiology (ESC), and ESC Committee for Practice Guidelines (CPG)
Published: 2020

5. Corrigendum to “2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk” (Atherosclerosis (2019) 290 (140–205), (S0021915019314595), (10.1016/j.atherosclerosis.2019.08.014))

Author: Interne Geneeskunde Vasculaire, Circulatory Health, Cardiovasculaire Epi Team 9, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, Task Force Members, ESC National Cardiac Societies, ESC Committee for Practice Guidelines (CPG), Interne Geneeskunde Vasculaire, Circulatory Health, Cardiovasculaire Epi Team 9, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, Task Force Members, ESC National Cardiac Societies, and ESC Committee for Practice Guidelines (CPG)
Published: 2020

6. Questions and Answers on Diagnosis and Management of Patients with Peripheral Arterial Diseases: A Companion Document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)

Author: Aboyans, Victor, Björck, Martin, Brodmann, Marianne, Collet, Jean-Philippe, Czerny, Martin, De Carlo, Marco, Naylor, A. Ross, Roffi, Marco, Tendera, Michal, Vlachopoulos, Charalambos, Ricco, Jean-Baptiste, Document Reviewers, Widimsky, Petr, Kolh, Philippe, Dick, Florian, Vega de Ceniga, Melina, Piepoli, Massimo Francesco, Sievert, Horst, Sulzenko, Jakub, ESC Committee for Practice Guidelines (CPG), Windecker, Stephan, Agewall, Stefan, Barbato, Emanuele, Bueno, Héctor, Coca, Antonio, Coman, Ioan Mircea, Dean, Veronica, Delgado, Victoria, Fitzsimons, Donna, Gaemperli, Oliver, Hindricks, Gerhard, Iung, Bernard, Jüni, Peter, Katus, Hugo A., Knuuti, Juhani, Lancellotti, Patrizio, Leclercq, Christophe, McDonagh, Theresa, Ponikowski, Piotr, Richter, Dimitrios J., Shlyakhto, Evgeny, Simpson, Iain A., and Zamorano, Jose Luis
Published: 2018
Full Text: View/download PDF

7. Questions and Answers on Diagnosis and Management of Patients with Peripheral Arterial Diseases: A Companion Document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)

Author: Victor Aboyans, Martin Björck, Marianne Brodmann, Jean-Philippe Collet, Martin Czerny, Marco De Carlo, A. Ross Naylor, Marco Roffi, Michal Tendera, Charalambos Vlachopoulos, Jean-Baptiste Ricco, null Document Reviewers, Petr Widimsky, Philippe Kolh, Florian Dick, Melina Vega de Ceniga, Massimo Francesco Piepoli, Horst Sievert, Jakub Sulzenko, null ESC Committee for Practice Guidelines (CPG), Stephan Windecker, Stefan Agewall, Emanuele Barbato, Héctor Bueno, Antonio Coca, Ioan Mircea Coman, Veronica Dean, Victoria Delgado, Donna Fitzsimons, Oliver Gaemperli, Gerhard Hindricks, Bernard Iung, Peter Jüni, Hugo A. Katus, Juhani Knuuti, Patrizio Lancellotti, Christophe Leclercq, Theresa McDonagh, Piotr Ponikowski, Dimitrios J. Richter, Evgeny Shlyakhto, Iain A. Simpson, Jose Luis Zamorano, Aboyans, Victor, Björck, Martin, Brodmann, Marianne, Collet, Jean-Philippe, Czerny, Martin, De Carlo, Marco, Naylor, A Ro, Roffi, Marco, Tendera, Michal, Vlachopoulos, Charalambo, Ricco, Jean-Baptiste, Document Reviewers, Null, Widimsky, Petr, Kolh, Philippe, Dick, Florian, de Ceniga, Melina Vega, Piepoli, Massimo Francesco, Sievert, Horst, Sulzenko, Jakub, Esc Committee For Practice Guidelines Cpg, Null, Windecker, Stephan, Agewall, Stefan, Barbato, Emanuele, Bueno, Héctor, Coca, Antonio, Coman, Ioan Mircea, Dean, Veronica, Delgado, Victoria, Fitzsimons, Donna, Gaemperli, Oliver, Hindricks, Gerhard, Iung, Bernard, Jüni, Peter, Katus, Hugo A, Knuuti, Juhani, Lancellotti, Patrizio, Leclercq, Christophe, Mcdonagh, Theresa, Ponikowski, Piotr, Richter, Dimitrios J, Shlyakhto, Evgeny, Simpson, Iain A, and Zamorano, Jose Luis
Subjects: Questions and answers, Diagnostic Imaging, Male, medicine.medical_specialty, Pathology, Consensus, Questions and answer, Arterial disease, Upper extremity artery disease, 030204 cardiovascular system & hematology, Guideline, Multisite artery disease, 03 medical and health sciences, 0302 clinical medicine, Renal artery disease, Carotid artery disease, Peripheral arterial disease, medicine, Humans, Mesenteric artery disease, Intensive care medicine, Vertebral artery disease, Societies, Medical, Aged, Aged, 80 and over, business.industry, Vascular surgery, Middle Aged, medicine.disease, Lower extremity artery disease, Peripheral Arterial Diseases, Europe, Practice Guidelines as Topic, Surgery, Female, Cardiology and Cardiovascular Medicine, business, Vascular Surgical Procedures, 030217 neurology & neurosurgery
Abstract: Questions and Answers on Diagnosis and Management of Patients with Peripheral Arterial Diseases : A Companion Document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS).
Published: 2018

8. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

Author: Interne Geneeskunde Vasculaire, Circulatory Health, Authors/Task Force members, ESC Committee for Practice Guidelines (CPG), ESC National Cardiac Societies, Interne Geneeskunde Vasculaire, Circulatory Health, Authors/Task Force members, ESC Committee for Practice Guidelines (CPG), and ESC National Cardiac Societies
Published: 2019

9. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

Author: Valgimigli, Marco, Bueno, Héctor, Byrne, Robert A, Collet, Jean-Philippe, Costa, Francesco, Jeppsson, Anders, Jüni, Peter, Kastrati, Adnan, Kolh, Philippe, Mauri, Laura, Montalescot, Gilles, Neumann, Franz-Josef, Petricevic, Mate, Roffi, Marco, Steg, Philippe Gabriel, Windecker, Stephan, Zamorano, Jose Luis, Levine, Glenn N, Badimon, Lina, Vranckx, Pascal, Agewall, Stefan, Andreotti, Felicita, Antman, Elliott, Barbato, Emanuele, Bassand, Jean-Pierre, Bugiardini, Raffaele, Cikirikcioglu, Mustafa, Cuisset, Thomas, De Bonis, Michele, Delgado, Victora, Fitzsimons, Donna, Gaemperli, Oliver, Galiè, Nazzareno, Gilard, Martine, Hamm, Christian W, Ibanez, Borja, Iung, Bernard, James, Stefan, Knuuti, Juhani, Landmesser, Ulf, Leclercq, Christophe, Lettino, Maddalena, Lip, Gregory, Piepoli, Massimo Francesco, Pierard, Luc, Schwerzmann, Markus, Sechtem, Udo, Simpson, Iain A, Uva, Miguel Sousa, Stabile, Eugenio, Storey, Robert F, Tendera, Michal, Van de Werf, Frans, Verheugt, Freek, Aboyans, Victor, Coca, Antonio, Collet, Jean- Philippe, Coman, Ioan Mircea, Dean, Veronica, Delgado, Victoria, Hindricks, Gerhard, Katus, Hugo A, Lancellotti, Patrizio, McDonagh, Theresa, Ponikowski, Piotr, Richter, Dimitrios J, Shlyakhto, Evgeny, Roithinger, Franz Xaver, Aliyev, Farid, Stelmashok, Valeriy, Desmet, Walter, Postadzhiyan, Arman, Georghiou, Georgios P, Motovska, Zuzana, Grove, Erik Lerkevang, Marandi, Toomas, Kiviniemi, Tuomas, Kedev, Sasko, Massberg, Steffen, Alexopoulos, Dimitrios, Kiss, Robert Gabor, Gudmundsdottir, Ingibjorg Jona, McFadden, Eugène P, Lev, Eli, De Luca, Leonardo, Sugraliyev, Akhmetzhan, Haliti, Edmond, Mirrakhimov, Erkin, Latkovskis, Gustavs, Petrauskiene, Birute, Huijnen, Steve, Magri, Caroline Jane, Cherradi, Rhizlan, Ten Berg, Jurrien M, Eritsland, Jan, Budaj, Andrzej, Aguiar, Carlos Tavares, Duplyakov, Dmitry, Zavatta, Marco, Antonijevic, Nebojsa M, Fras, Zlatko, Montoliu, Antonio Tello, Varenhorst, Christoph, Tsakiris, Dimitri, Addad, Faouzi, Aydogdu, Sinan, Parkhomenko, Alexander, Kinnaird, Tim, ESC Scientific Document Group, ESC Committee for Practice Guidelines (CPG), ESC National Cardiac Societies, Valgimigli, Marco, Bueno, Héctor, Byrne, Robert A., Collet, Jean-Philippe, Costa, Francesco, Jeppsson, Ander, Kastrati, Adnan, Kolh, Philippe, Mauri, Laura, Montalescot, Gille, Neumann, Franz-Josef, Petricevic, Mate, Roffi, Marco, Steg, Philippe Gabriel, Zamorano, Jose Lui, Levine, Glenn N., Badimon, Lina, Vranckx, Pascal, Agewall, Stefan, Andreotti, Felicita, Antman, Elliott, Barbato, Emanuele, Bassand, Jean-Pierre, Bugiardini, Raffaele, Cikirikcioglu, Mustafa, Cuisset, Thoma, De Bonis, Michele, Delgado, Victora, Fitzsimons, Donna, Galiè, Nazzareno, Gilard, Martine, Hamm, Christian W., Ibanez, Borja, James, Stefan, Knuuti, Juhani, Landmesser, Ulf, Leclercq, Christophe, Lettino, Maddalena, Lip, Gregory, Piepoli, Massimo Francesco, Pierard, Luc, Schwerzmann, Marku, Sechtem, Udo, Simpson, Iain A., Uva, Miguel Sousa, Stabile, Eugenio, Storey, Robert F., Tendera, Michal, Van De Werf, Fran, Verheugt, Freek, Aboyans, Victor, Windecker, Stephan, Coca, Antonio, Coman, Ioan Mircea, Dean, Veronica, Delgado, Victoria, Gaemperli, Oliver, Hindricks, Gerhard, Iung, Bernard, Jüni, Peter, Katus, Hugo A., Lancellotti, Patrizio, McDonagh, Theresa, Ponikowski, Piotr, Richter, DImitrios J., Shlyakhto, Evgeny, Roithinger, Franz Xaver, Aliyev, Farid, Stelmashok, Valeriy, Desmet, Walter, Postadzhiyan, Arman, Georghiou, Georgios P., Motovska, Zuzana, Grove, Erik Lerkevang, Marandi, Tooma, Kiviniemi, Tuoma, Kedev, Sasko, Massberg, Steffen, Alexopoulos, DImitrio, Kiss, Robert Gabor, Gudmundsdottir, Ingibjorg Jona, McFadden, Eugène P., Lev, Eli, De Luca, Leonardo, Sugraliyev, Akhmetzhan, Haliti, Edmond, Mirrakhimov, Erkin, Latkovskis, Gustav, Petrauskiene, Birute, Huijnen, Steve, Magri, Caroline Jane, Cherradi, Rhizlan, Ten Berg, Jurrien M., Eritsland, Jan, Budaj, Andrzej, Aguiar, Carlos Tavare, Duplyakov, Dmitry, Zavatta, Marco, Antonijevic, Nebojsa M., Fras, Zlatko, Montoliu, Antonio Tello, Varenhorst, Christoph, Tsakiris, DImitri, Addad, Faouzi, Aydogdu, Sinan, Parkhomenko, Alexander, Kinnaird, Tim, Valgimigli, M, Bueno, H, Byrne, Ra, Collet, Jp, Costa, F, Jeppsson, A, Juni, P, Kastrati, A, Kolh, P, Mauri, L, Montalescot, G, Neumann, Fj, Petricevic, M, Roffi, M, Steg, Pg, Windecker, S, Zamorano, Jl, Levine, Gn, Badimon, L, Vranckx, P, Agewall, S, Andreotti, F, Antman, E, Barbato, E, Bassand, Jp, Bugiardini, R, Cikirikcioglu, M, Cuisset, T, De Bonis, M, Delgado, V, Fitzsimons, D, Oliver, G, Galie, N, Gilard, M, Hamm, Cw, Ibanez, B, Iung, B, James, S, Knuuti, J, Landmesser, U, Leclercq, C, Lettino, M, Lip, G, Piepoli, Mf, Pierard, L, Schwerzmann, M, Sechtem, U, Simpson, Ia, Uva, M, Stabile, E, Storey, Rf, Tendera, M, Van De Werf, F, Verheugt, F, Aboyans, V, Byrne, Robert A, Levine, Glenn N, Badimon L, Vranckx P, Agewall S, Andreotti F, Antman E, Barbato E, Bassand JP, Bugiardini R, Cikirikcioglu M, Cuisset T, De Bonis M, Delgado V, Fitzsimons D, Gaemperli O, Galiè N, Gilard M, Hamm CW, Ibanez B, Iung B, James S, Knuuti J, Landmesser U, Leclercq C, Lettino M, Lip G, Piepoli MF, Pierard L, Schwerzmann M, Sechtem U, Simpson IA, Uva MS, Stabile E, Storey RF, Tendera M, Van de Werf F, Verheugt F, Aboyans V, Alma Mater Studiorum Universita' di Bologna, DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE, DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE, Da definire, and AREA MIN. 06 - Scienze mediche
Subjects: Stable angina, Ticagrelor, Prasugrel, Stent thrombosi, Stent thrombosis, medicine.medical_treatment, Vascular damage Radboud Institute for Health Sciences [Radboudumc 16], Coronary artery bypass grafting, 030204 cardiovascular system & hematology, Guideline, Coronary artery disease, Percutaneous coronary intervention, 0302 clinical medicine, Stent, DAPT score, 030212 general & internal medicine, Myocardial infarction, Drug-eluting stents, reproductive and urinary physiology, Societies, Medical, dual antiplatelet therapy, coronary artery disease, General Medicine, Clopidogrel, Europe, Cardiothoracic surgery, Non cardiac surgery, embryonic structures, Dual antiplatelet therapy, Cardiology, Stents, Stable coronary artery disease, Radiology, Acute coronary syndrome, biological phenomena, cell phenomena, and immunity, Cardiology and Cardiovascular Medicine, PRECISE-DAPT score, circulatory and respiratory physiology, medicine.drug, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Acute coronary syndromes, Guidelines, 03 medical and health sciences, Non-cardiac surgery, Internal medicine, medicine, Humans, cardiovascular diseases, Triple therapy, Risk stratification, Aspirin, business.industry, urogenital system, Revascularization, Bleeding, Oral anticoagulant, Recommendation, medicine.disease, Settore MED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLARE, Surgery, Drug-eluting stent, business, Platelet Aggregation Inhibitors
Abstract: none 107 si Non presente mixed Valgimigli, Marco*; Bueno, Héctor; Byrne, Robert A.; Collet, Jean-Philippe; Costa, Francesco; Jeppsson, Anders; Kastrati, Adnan; Kolh, Philippe; Mauri, Laura; Montalescot, Gilles; Neumann, Franz-Josef; Petricevic, Mate; Roffi, Marco; Steg, Philippe Gabriel; Zamorano, Jose Luis; Levine, Glenn N.; Badimon, Lina; Vranckx, Pascal; Agewall, Stefan; Andreotti, Felicita; Antman, Elliott; Barbato, Emanuele; Bassand, Jean-Pierre; Bugiardini, Raffaele; Cikirikcioglu, Mustafa; Cuisset, Thomas; De Bonis, Michele; Delgado, Victora; Fitzsimons, Donna; Galiè, Nazzareno; Gilard, Martine; Hamm, Christian W.; Ibanez, Borja; James, Stefan; Knuuti, Juhani; Landmesser, Ulf; Leclercq, Christophe; Lettino, Maddalena; Lip, Gregory; Piepoli, Massimo Francesco; Pierard, Luc; Schwerzmann, Markus; Sechtem, Udo; Simpson, Iain A.; Uva, Miguel Sousa; Stabile, Eugenio; Storey, Robert F.; Tendera, Michal; Van De Werf, Frans; Verheugt, Freek; Aboyans, Victor; Windecker, Stephan; Coca, Antonio; Coman, Ioan Mircea; Dean, Veronica; Delgado, Victoria; Gaemperli, Oliver; Hindricks, Gerhard; Iung, Bernard; Jüni, Peter; Katus, Hugo A.; Lancellotti, Patrizio; McDonagh, Theresa; Ponikowski, Piotr; Richter, DImitrios J.; Shlyakhto, Evgeny; Roithinger, Franz Xaver; Aliyev, Farid; Stelmashok, Valeriy; Desmet, Walter; Postadzhiyan, Arman; Georghiou, Georgios P.; Motovska, Zuzana; Grove, Erik Lerkevang; Marandi, Toomas; Kiviniemi, Tuomas; Kedev, Sasko; Massberg, Steffen; Alexopoulos, DImitrios; Kiss, Robert Gabor; Gudmundsdottir, Ingibjorg Jona; McFadden, Eugène P.; Lev, Eli; De Luca, Leonardo; Sugraliyev, Akhmetzhan; Haliti, Edmond; Mirrakhimov, Erkin; Latkovskis, Gustavs; Petrauskiene, Birute; Huijnen, Steve; Magri, Caroline Jane; Cherradi, Rhizlan; Ten Berg, Jurrien M.; Eritsland, Jan; Budaj, Andrzej; Aguiar, Carlos Tavares; Duplyakov, Dmitry; Zavatta, Marco; Antonijevic, Nebojsa M.; Fras, Zlatko; Montoliu, Antonio Tello; Varenhorst, Christoph; Tsakiris, DImitri; Addad, Faouzi; Aydogdu, Sinan; Parkhomenko, Alexander; Kinnaird, Tim Valgimigli, Marco*; Bueno, Héctor; Byrne, Robert A.; Collet, Jean-Philippe; Costa, Francesco; Jeppsson, Anders; Kastrati, Adnan; Kolh, Philippe; Mauri, Laura; Montalescot, Gilles; Neumann, Franz-Josef; Petricevic, Mate; Roffi, Marco; Steg, Philippe Gabriel; Zamorano, Jose Luis; Levine, Glenn N.; Badimon, Lina; Vranckx, Pascal; Agewall, Stefan; Andreotti, Felicita; Antman, Elliott; Barbato, Emanuele; Bassand, Jean-Pierre; Bugiardini, Raffaele; Cikirikcioglu, Mustafa; Cuisset, Thomas; De Bonis, Michele; Delgado, Victora; Fitzsimons, Donna; Galiè, Nazzareno; Gilard, Martine; Hamm, Christian W.; Ibanez, Borja; James, Stefan; Knuuti, Juhani; Landmesser, Ulf; Leclercq, Christophe; Lettino, Maddalena; Lip, Gregory; Piepoli, Massimo Francesco; Pierard, Luc; Schwerzmann, Markus; Sechtem, Udo; Simpson, Iain A.; Uva, Miguel Sousa; Stabile, Eugenio; Storey, Robert F.; Tendera, Michal; Van De Werf, Frans; Verheugt, Freek; Aboyans, Victor; Windecker, Stephan; Coca, Antonio; Coman, Ioan Mircea; Dean, Veronica; Delgado, Victoria; Gaemperli, Oliver; Hindricks, Gerhard; Iung, Bernard; Jüni, Peter; Katus, Hugo A.; Lancellotti, Patrizio; McDonagh, Theresa; Ponikowski, Piotr; Richter, DImitrios J.; Shlyakhto, Evgeny; Roithinger, Franz Xaver; Aliyev, Farid; Stelmashok, Valeriy; Desmet, Walter; Postadzhiyan, Arman; Georghiou, Georgios P.; Motovska, Zuzana; Grove, Erik Lerkevang; Marandi, Toomas; Kiviniemi, Tuomas; Kedev, Sasko; Massberg, Steffen; Alexopoulos, DImitrios; Kiss, Robert Gabor; Gudmundsdottir, Ingibjorg Jona; McFadden, Eugène P.; Lev, Eli; De Luca, Leonardo; Sugraliyev, Akhmetzhan; Haliti, Edmond; Mirrakhimov, Erkin; Latkovskis, Gustavs; Petrauskiene, Birute; Huijnen, Steve; Magri, Caroline Jane; Cherradi, Rhizlan; Ten Berg, Jurrien M.; Eritsland, Jan; Budaj, Andrzej; Aguiar, Carlos Tavares; Duplyakov, Dmitry; Zavatta, Marco; Antonijevic, Nebojsa M.; Fras, Zlatko; Montoliu, Antonio Tello; Varenhorst, Christoph; Tsakiris, DImitri; Addad, Faouzi; Aydogdu, Sinan; Parkhomenko, Alexander; Kinnaird, Tim
Published: 2018

10. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

Author: Rydén, L, Grant, Pj, Anker, Sd, Berne, C, Cosentino, F, Danchin, N, Deaton, C, Escaned, J, Hammes, Hp, Huikuri, H, Marre, M, Marx, N, Mellbin, L, Ostergren, J, Patrono, C, Seferovic, P, Uva, Ms, Taskinen, Mr, Tendera, M, Tuomilehto, J, Valensi, P, Zamorano, Jl, Achenbach, S, Baumgartner, H, Bax, Jj, Bueno, H, Dean, V, Erol, C, Fagard, R, Ferrari, R, Hasdai, D, Hoes, Aw, Kirchhof, P, Knuuti, J, Kolh, P, Lancellotti, P, Linhart, A, Nihoyannopoulos, P, Piepoli, Mf, Ponikowski, P, Sirnes, Pa, Tamargo, Jl, Torbicki, A, Wijns, W, Windecker, S, De Backer, G, Ezquerra, Ea, Avogaro, Angelo, Badimon, L, Baranova, E, Betteridge, J, Ceriello, A, Funck Brentano, C, Gulba, Dc, Kjekshus, Jk, Lev, E, Mueller, C, Neyses, L, Nilsson, Pm, Perk, J, Reiner, Z, Sattar, N, Schächinger, V, Scheen, A, Schirmer, H, Strömberg, A, Sudzhaeva, S, Viigimaa, M, Vlachopoulos, C, Xuereb, Rg, Authors/Task Force Members, ESC Committee for Practice Guidelines, and Document, Reviewers
Subjects: Male, Epidemiology, Smoking Prevention, Impaired glucose tolerance, Diabetes mellitus, Patient-Centered Care, Medicine, Child, Diagnostics, Smoking, Middle Aged, Cardiovascular disease, Prognosis, Patient management, Coronary Interventions, Cardiovascular Diseases, Pre diabetes, Child, Preschool, Female, Cardiology and Cardiovascular Medicine, Pharmacological treatment, Adult, medicine.medical_specialty, Adolescent, 610 Medicine & health, Guidelines, Prediabetic State, Young Adult, Internal medicine, Humans, Exercise, Aged, Glycated Hemoglobin, business.industry, Task force, Prevention, Settore MED/09 - MEDICINA INTERNA, Infant, medicine.disease, Diet, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Risk factors, business, Diabetic Angiopathies
Published: 2013
Full Text: View/download PDF

11. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)

Author: Zamorano, JL, Lancellotti, P, Rodriguez Muñoz, D, Aboyans, V, Asteggiano, R, Galderisi, M, Habib, G, Lenihan, DJ, Lip, GY, Lyon, AR, Lopez Fernandez, T, Mohty, D, Piepoli, MF, Tamargo, J, Torbicki, A, Suter, TM, Achenbach, S, Agewall, S, Badimon, L, Barón-Esquivias, G, Baumgartner, H, Bax, JJ, Bueno, H, Carerj, S, Dean, V, Erol, Ç, Fitzsimons, D, Gaemperli, O, Kirchhof, P, Kolh, P, Nihoyannopoulos, P, Ponikowski, P, Roffi, M, Vaz Carneiro, A, Windecker, S, Authors/Task Force Members, ESC Committee for Practice Guidelines (CPG), University of Zurich, Zamorano, Jose Luis, Centre Hospitalier Universitaire de Liège (CHU-Liège), Neuroépidémiologie Tropicale (NET), CHU Limoges-Institut d'Epidémiologie Neurologique et de Neurologie Tropicale-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST), Université de Limoges (UNILIM)-Université de Limoges (UNILIM), Università degli studi di Napoli Federico II, Unité de Recherche sur les Maladies Infectieuses Tropicales Emergentes (URMITE), Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (URMITE), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR48, INSB-INSB-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR48, INSB-INSB-Centre National de la Recherche Scientifique (CNRS), British Heart Foundation, Action Against Cancer, Zamorano, Jose Lui, Lancellotti, Patrizio, Rodriguez Muñoz, Daniel, Aboyans, Victor, Asteggiano, Riccardo, Galderisi, Maurizio, Habib, Gilbert, Lenihan, Daniel J., Lip, Gregory Y. H., Lyon, Alexander R., Lopez Fernandez, Teresa, Mohty, Dania, Piepoli, Massimo F., Tamargo, Juan, Torbicki, Adam, Suter, Thomas M., Achenbach, Stephan, Agewall, Stefan, Badimon, Lina, Barón Esquivias, Gonzalo, Baumgartner, Helmut, Bax, Jeroen J., Bueno, Héctor, Carerj, Scipione, Dean, Veronica, Erol, Çetin, Fitzsimons, Donna, Gaemperli, Oliver, Kirchhof, Paulu, Kolh, Philippe, Nihoyannopoulos, Petro, Ponikowski, Piotr, Roffi, Marco, Vaz Carneiro, António, Windecker, Stephan, Lenihan, Daniel J, Lip, Gregory Y. H, Lyon, Alexander R, Piepoli, Massimo F, University of Naples Federico II = Università degli studi di Napoli Federico II, Institut des sciences biologiques (INSB-CNRS)-Institut des sciences biologiques (INSB-CNRS)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR48, and Institut des sciences biologiques (INSB-CNRS)-Institut des sciences biologiques (INSB-CNRS)-Centre National de la Recherche Scientifique (CNRS)
Subjects: Vascular Endothelial Growth Factor A, Angiotensin receptor, Cardiac & Cardiovascular Systems, cardio-oncology, medicine.medical_treatment, myocardial dysfunction, 030204 cardiovascular system & hematology, ANTHRACYCLINE-INDUCED CARDIOMYOPATHY, chemotherapy, Coronary artery disease, 0302 clinical medicine, RENAL-CELL CARCINOMA, Authors/Task Force Members, Cancer Survivors, Neoplasms, Natriuretic peptide, 610 Medicine & health, early detection, ComputingMilieux_MISCELLANEOUS, Societies, Medical, HER2-POSITIVE BREAST-CANCER, TRASTUZUMAB-INDUCED CARDIOTOXICITY, Chemotherapy regimen, 3. Good health, Europe, medicine.anatomical_structure, 030220 oncology & carcinogenesis, CHEMOTHERAPY-INDUCED CARDIOTOXICITY, Practice Guidelines as Topic, cardiovascular system, Cardiology, surveillance, 10209 Clinic for Cardiology, cancer therapy, CORONARY-ARTERY-DISEASE, ESC Committee for Practice Guidelines (CPG), ischaemia, Immunotherapy, Cardiology and Cardiovascular Medicine, Life Sciences & Biomedicine, arrhythmias, Arrhythmia, Artery, Cardiovascular toxicity, medicine.medical_specialty, Heart Diseases, medicine.drug_class, Advisory Committees, Cancer therapy, Early detection, Antineoplastic Agents, [SDV.MHEP.CHI]Life Sciences [q-bio]/Human health and pathology/Surgery, 1102 Cardiovascular Medicine And Haematology, 2705 Cardiology and Cardiovascular Medicine, European Society of Cardiology, 03 medical and health sciences, LEFT-VENTRICULAR DYSFUNCTION, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Internal medicine, medicine, TYROSINE KINASE INHIBITORS, Humans, cardiovascular diseases, Intensive care medicine, ACUTE LYMPHOBLASTIC-LEUKEMIA, Cardiotoxicity, Science & Technology, CONGESTIVE-HEART-FAILURE, Radiotherapy, business.industry, Arrhythmias, Cardio-oncology, Chemotherapy, Ischaemia, Myocardial dysfunction, Surveillance, Cancer, 10181 Clinic for Nuclear Medicine, Congresses as Topic, medicine.disease, Radiation therapy, Cardiovascular System & Hematology, Cardiovascular System & Cardiology, Position paper, business, human activities, Document Reviewers
Abstract: 2-D : two-dimensional 3-D : three-dimensional 5-FU : 5-fluorouracil ACE : angiotensin-converting enzyme ARB : angiotensin II receptor blocker ASE : American Society of Echocardiography BNP : B-type natriuretic peptide CABG : coronary artery bypass graft CAD : coronary artery
Published: 2016
Full Text: View/download PDF

12. Third universal definition of myocardial infarction

Author: Thygesen, K, Alpert, Js, Jaffe, As, Simoons, Ml, Chaitman, Br, White, Hd, the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, Authors/Task Force Members Chairpersons, Biomarker, Subcommittee, Katus, Ha, Apple, Fs, Lindahl, B, Morrow, Da, Ecg, Subcommittee, Clemmensen, Pm, Johanson, P, Hod, H, Imaging, Subcommittee, Underwood, R, Bax, Jj, Bonow, Ro, Pinto, F, Gibbons, Rj, Classification, Subcommittee, Fox, Ka, Atar, D, Newby, Lk, Galvani, M, Hamm, Cw, Intervention, Subcommittee, Uretsky, Bf, Gabriel Steg, P, Wijns, W, Bassand, Jp, Menasché, P, Ravkilde, J, Trials, Registries, Subcommittee, Ohman, Em, Antman, Em, Wallentin, Lc, Armstrong, Pw, Heart Failure Subcommittee, Januzzi, Jl, Nieminen, Ms, Gheorghiade, M, Filippatos, G, Epidemiology, Subcommittee, Luepker, Rv, Fortmann, Sp, Rosamond, Wd, Levy, D, Wood, D, Global Perspective Subcommittee, Smith, Sc, Hu, D, Lopez Sendon JL, Robertson, Rm, Weaver, D, Tendera, M, Bove, Aa, Parkhomenko, An, Vasilieva, Ej, Mendis, S, ESC Committee for Practice Guidelines, Baumgartner, H, Ceconi, Claudio, Dean, V, Deaton, C, Fagard, R, Funck Brentano, C, Hasdai, D, Hoes, A, Kirchhof, P, Knuuti, J, Kolh, P, Mcdonagh, T, Moulin, C, Popescu, Ba, Reiner, Z, Sechtem, U, Sirnes, Pa, Torbicki, A, Vahanian, A, Windecker, S, Document, Reviewers, Morais, J, Aguiar, C, Almahmeed, W, Arnar, Do, Barili, F, Bloch, Kd, Bolger, Af, Bøtker, He, Bozkurt, B, Bugiardini, R, Cannon, C, de Lemos, J, Eberli, Fr, Escobar, E, Hlatky, M, James, S, Kern, Kb, Moliterno, Dj, Mueller, C, Neskovic, An, Pieske, Bm, Schulman, Sp, Storey, Rf, Taubert, Ka, Vranckx, P, Wagner, D. R., Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Lindahl B, Morrow DA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow JJ, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasche P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Torbicki A, Vahanian A, Windecker S, Morais J, Aguiar C, Almahmeed W, Arnar DO, Barili F, Bloch KD, Bolger AF, Botker HE, Bozkurt B, Bugiardini R, Cannon C, de Lemos J, Eberli FR, Escobar E, Hlatky M, James S, Kern KB, Moliterno DJ, Mueller C, Neskovic AN, Pieske BM, Schulman SP, Storey RF, Taubert KA, Vranckx P, Wagner DR., Cardiology, lLindahl B, K. Thygesen, J. S. Alpert, A. S. Jaffe, M. L. Simoon, B. R. Chaitman, H. D. White, H. A. Katu, F. S. Apple, B. Lindahl, D. A. Morrow, P. M. Clemmensen, P. Johanson, H. Hod, R. Underwood, J. J. Bax, R. O. Bonow, F. Pinto, R. J. Gibbon, K. A. Fox, D. Atar, L. K. Newby, M. Galvani, C. W. Hamm, B. F. Uretsky, P. Gabriel Steg, W. Wijn, J.-P. Bassand, P. Menasche, J. Ravkilde, E. M. Ohman, E. M. Antman, L. C. Wallentin, P. W. Armstrong, J. L. Januzzi, M. S. Nieminen, M. Gheorghiade, G. Filippato, R. V. Luepker, S. P. Fortmann, W. D. Rosamond, D. Levy, D. Wood, S. C. Smith, D. Hu, J.-L. Lopez-Sendon, R. M. Robertson, D. Weaver, M. Tendera, A. A. Bove, A. N. Parkhomenko, E. J. Vasilieva, S. Mendi, H. Baumgartner, C. Ceconi, V. Dean, C. Deaton, R. Fagard, C. Funck-Brentano, D. Hasdai, A. Hoe, P. Kirchhof, J. Knuuti, P. Kolh, T. McDonagh, C. Moulin, B. A. Popescu, Z. Reiner, U. Sechtem, P. A. Sirne, A. Torbicki, A. Vahanian, S. Windecker, J. Morai, C. Aguiar, W. Almahmeed, D. O. Arnar, F. Barili, K. D. Bloch, A. F. Bolger, H. E. Botker, B. Bozkurt, R. Bugiardini, C. Cannon, J. de Lemo, F. R. Eberli, E. Escobar, M. Hlatky, S. Jame, K. B. Kern, D. J. Moliterno, C. Mueller, A. N. Neskovic, B. M. Pieske, S. P. Schulman, R. F. Storey, K. A. Taubert, P. Vranckx, D. R. Wagner, Thygesen, K, Alpert, J, Jaffe, A, Simoons, Ml, Chaitman, Br, White, Hd, Katus, Ha, Apple, F, Lindahl, B, Morrow, Da, Clemmensen, Pm, Johanson, P, Hod, H, Underwood, R, Bax, Jj, Bonow, Jj, Pinto, F, Gibbons, Rj, Fox, Ka, Atar, D, Newby, Lk, Galvani, M, Hamm, Cw, Uretsky, Bf, Steg, Pg, Wijns, W, Bassand, Jp, Menasche, P, Ravkilde, J, Ohman, Em, Antman, Em, Wallentin, Lc, Armstrong, Pw, Januzzi, Jl, Nieminen, M, Gheorghiade, M, Filippatos, G, Luepker, Rv, Fortmann, Sp, Rosamond, Wd, Levy, D, Wood, D, Smith, Sc, Hu, D, Lopez-Sendon, Jl, Robertson, Rm, Weaver, D, Tendera, M, Bove, Aa, Parkhomenko, An, Vasilieva, Ej, Mendis, S, Baumgartner, H, Ceconi, C, Dean, V, Deaton, C, Fagard, R, Funck-Brentano, C, Hasdai, D, Hoes, A, Kirchhof, P, Knuuti, J, Kolh, P, Mcdonagh, T, Moulin, C, Popescu, Ba, Reiner, Z, Sechtem, U, Sirnes, Pa, Torbicki, A, Vahanian, A, Windecker, S, Morais, J, Aguiar, C, Almahmeed, W, Arnar, Do, Barili, F, Bloch, Kd, Bolger, Af, Botker, He, Bozkurt, B, Bugiardini, R, Cannon, C, de Lemos, J, Eberli, Fr, Escobar, E, Hlatky, M, James, S, Kern, Kb, Moliterno, Dj, Mueller, C, Neskovic, An, Pieske, Bm, Schulman, Sp, Storey, Rf, Taubert, Ka, Vranckx, P, and Wagner, Dr
Subjects: High-sensitivity troponin, Ticagrelor, Chest pain unit, Quality Assurance, Health Care, Epidemiology, medicine.medical_treatment, Myocardial Infarction, Myocardial ischaemia, Global Health, Early invasive strategy, Electrocardiography, Stent, Myocardial Revascularization, Myocardial infarction, Coronary Artery Bypass, Intraoperative Complications, Left bundle branch block, Health Policy, Electrocardiography in myocardial infarction, Cangrelor, Stents, Acute coronary syndrome, Cardiology and Cardiovascular Medicine, Prasugrel, Diagnostic Imaging, medicine.medical_specialty, Public Policy, Risk Assessment, Vorapaxar, Percutaneous Coronary Intervention, Physiology (medical), Terminology as Topic, Humans, Enoxaparin, Bypass surgery, Community and Home Care, Heart Failure, Rhythm monitoring, Aspirin, Unstable angina, Angioplasty, Recommendation, ta3121, medicine.disease, Myocardial infarction diagnosis, Bivalirudin, Biomarkers, Time Factors, Platelet inhibition, Consensus Development Conferences as Topic, Diagnostic Techniques, Cardiovascular, Myocardial Ischemia, Guideline, Diabete, Nitrate, Left ventricular hypertrophy, Coronary artery disease, Rivaroxaban, Recurrence, Apixaban, Clinical Trials as Topic, Graft Occlusion, Vascular, Atherothrombosi, Acute cardiac care, Right bundle branch block, Clopidogrel, Dabigatran, Prosthesis Failure, AHA Scientific Statements, Practice Guidelines as Topic, Cardiology, Biological Markers, Radiology, Critical Care, Glycoprotein IIb/IIIa inhibitor, European Society of Cardiology, Diagnosis, Differential, Anticoagulation, Internal medicine, medicine, Beta-blocker, cardiovascular diseases, Heparin, business.industry, Revascularization, Cardiovascular Surgical Procedures, MYOCARDIAL INFARCTION, Statin, Percutaneous coronary intervention, Arrhythmias, Cardiac, Cardiac Imaging Techniques, Fondaparinux, Heart failure, Non-ST-elevation myocardial infarction, business
Abstract: ACCF : American College of Cardiology Foundation ACS : acute coronary syndrome AHA : American Heart Association CAD : coronary artery disease CABG : coronary artery bypass grafting CKMB : creatine kinase MB isoform cTn : cardiac troponin CT : computed tomography CV : coefficient of variation ECG : electrocardiogram ESC : European Society of Cardiology FDG : fluorodeoxyglucose h : hour(s) HF : heart failure LBBB : left bundle branch block LV : left ventricle LVH : left ventricular hypertrophy MI : myocardial infarction mIBG : meta-iodo-benzylguanidine min : minute(s) MONICA : Multinational MONItoring of trends and determinants in CArdiovascular disease) MPS : myocardial perfusion scintigraphy MRI : magnetic resonance imaging mV : millivolt(s) ng/L : nanogram(s) per litre Non-Q MI : non-Q wave myocardial infarction NSTEMI : non-ST-elevation myocardial infarction PCI : percutaneous coronary intervention PET : positron emission tomography pg/mL : pictogram(s) per millilitre Q wave MI : Q wave myocardial infarction RBBB : right bundle branch block sec : second(s) SPECT : single photon emission computed tomography STEMI : ST elevation myocardial infarction ST–T : ST-segment –T wave URL : upper reference limit WHF : World Heart Federation WHO : World Health Organization Myocardial infarction (MI) can be recognised by clinical features, including electrocardiographic (ECG) findings, elevated values of biochemical markers (biomarkers) of myocardial necrosis, and by imaging, or may be defined by pathology. It is a major cause of death and disability worldwide. MI may be the first manifestation of coronary artery disease (CAD) or it may occur, repeatedly, in patients with established disease. Information on MI rates can provide useful information regarding the burden of CAD within and across populations, especially if standardized data are collected in a manner that …
Published: 2012
Full Text: View/download PDF

13. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association

Author: Camm, A. J., Lip, G. Y., Caterina, R., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Paulus Kirchhof, Esc, Committee For Practice Guidelines-Cpg, and Document Reviewers
Subjects: Cardiovascular diseases [NCEBP 14]
Abstract: Item does not contain fulltext
Published: 2012
Full Text: View/download PDF

14. Guidelines for the management of atrial fibrillation The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

Author: Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH, Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck Brentano C, Hobbs R, Kearney P, McDonagh T, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas PE, Widimsky P, Agladze V, Aliot E, Balabanski T, Blomstrom Lundqvist C, Capucci A, Crijns H, Dahlöf B, Folliguet T, Glikson M, Goethals M, Gulba DC, Ho SY, Klautz RJ, Kose S, McMurray J, PERRONE FILARDI, PASQUALE, Raatikainen P, Salvador MJ, Schalij MJ, Shpektor A, Sousa J, Stepinska J, Uuetoa H, Zamorano JL, Zupan I, European Heart Rhythm Association, European Association for Cardio Thoracic Surgery, ESC Committee for Practice Guidelines, Document Reviewers, Camm, Aj, Kirchhof, P, Lip, Gy, Schotten, U, Savelieva, I, Ernst, S, Van Gelder, Ic, Al Attar, N, Hindricks, G, Prendergast, B, Heidbuchel, H, Alfieri, O, Angelini, A, Atar, D, Colonna, P, De Caterina, R, De Sutter, J, Goette, A, Gorenek, B, Heldal, M, Hohloser, Sh, Kolh, P, Le Heuzey, Jy, Ponikowski, P, Rutten, Fh, Vahanian, A, Auricchio, A, Bax, J, Ceconi, C, Dean, V, Filippatos, G, Funck Brentano, C, Hobbs, R, Kearney, P, Mcdonagh, T, Popescu, Ba, Reiner, Z, Sechtem, U, Sirnes, Pa, Tendera, M, Vardas, Pe, Widimsky, P, Agladze, V, Aliot, E, Balabanski, T, Blomstrom Lundqvist, C, Capucci, A, Crijns, H, Dahlöf, B, Folliguet, T, Glikson, M, Goethals, M, Gulba, Dc, Ho, Sy, Klautz, Rj, Kose, S, Mcmurray, J, PERRONE FILARDI, Pasquale, Raatikainen, P, Salvador, Mj, Schalij, Mj, Shpektor, A, Sousa, J, Stepinska, J, Uuetoa, H, Zamorano, Jl, Zupan, I, European Heart Rhythm, Association, European Association for Cardio Thoracic, Surgery, ESC Committee for Practice, Guideline, Document, Reviewers, Alfieri, Ottavio, Ponikowski, P., Fysiologie, Cardiologie, RS: CARIM School for Cardiovascular Diseases, Camm, A. J, Lip, G, Van Gelder, I. C, Hohloser, S. H, and Le Heuzey, J. Y.
Subjects: Lung Diseases, Male, Rate control, Heart Valve Diseases, Management of atrial fibrillation, Angiotensin-Converting Enzyme Inhibitors, Comorbidity, Upstream therapy, Hyperthyroidism, law.invention, Cardiac Resynchronization Therapy, Electrocardiography, Ventricular Dysfunction, Left, Postoperative Complications, Atrial fibrillation European Society of Cardiology Guidelines Anticoagulation Rate control Rhythm control Upstream therapy Pulmonary vein isolation Left atrial ablation randomized controlled-trial congestive-heart-failure parkinson-white-syndrome cardiac resynchronization therapy angiotensin-converting enzyme polyunsaturated fatty-acids antiarrhythmic-drug therapy long-term survival radiofrequency catheter ablation placebo-controlled trial, Randomized controlled trial, Heart Rate, Pregnancy, Recurrence, law, Prevalence, Secondary Prevention, Medicine, Angioplasty, Balloon, Coronary, Precision Medicine, Mineralocorticoid Receptor Antagonists, Middle Aged, Congestive-Heart-Failure, Left atrial ablation, Primary Prevention, Stroke, Catheter Ablation, Cardiology, Female, Rhythm control, Cardiology and Cardiovascular Medicine, Risk assessment, Anti-Arrhythmia Agents, Sports, Radiofrequency Catheter Ablation, Adult, medicine.medical_specialty, Point-of-Care Systems, Angiotensin-Converting Enzyme, Antiarrhythmic-Drug Therapy, Placebo-Controlled Trial, Electric Countershock, MEDLINE, Hemorrhage, Guidelines, Parkinson-White-Syndrome, Risk Assessment, Pulmonary vein isolation, European Society of Cardiology, Anticoagulation, Fibrinolytic Agents, Thromboembolism, Internal medicine, Diabetes Mellitus, Humans, Polyunsaturated Fatty-Acids, International Normalized Ratio, Acute Coronary Syndrome, Randomized Controlled-Trial, Long-Term Survival, Aged, Heart Failure, Intraoperative Care, business.industry, Conflict of interest, Anticoagulants, Evidence-based medicine, Cardiomyopathy, Hypertrophic, Precision medicine, Atrial fibrillation, Athletes, CHA2DS2–VASc score, Quality of Life, Wolff-Parkinson-White Syndrome, Hydroxymethylglutaryl-CoA Reductase Inhibitors, business, Platelet Aggregation Inhibitors
Abstract: Guidelines summarize and evaluate all currently available evidence on a particular issue with the aim of assisting physicians in selecting the best management strategy for an individual patient suffering from a given condition, taking into account the impact on outcome, as well as the risk–benefit ratio of particular diagnostic or therapeutic means. Guidelines are no substitutes for textbooks. The legal implications of medical guidelines have been discussed previously. A large number of Guidelines have been issued in recent years by the European Society of Cardiology (ESC) as well as by other societies and organizations. Because of the impact on clinical practice, quality criteria for development of guidelines have been established in order to make all decisions transparent to the user. The recommendations for formulating and issuing ESC Guidelines can be found on the ESC Web Site (http://www.escardio.org/guidelines-surveys/esc-guidelines/about/Pages/rules-writing.aspx). In brief, experts in the field are selected and undertake a comprehensive review of the published evidence for management and/or prevention of a given condition. A critical evaluation of diagnostic and therapeutic procedures is performed, including assessment of the risk–benefit ratio. Estimates of expected health outcomes for larger societies are included, where data exist. The level of evidence and the strength of recommendation of particular treatment options are weighed and graded according to pre-defined scales, as outlined in Tables 1 and 2 . View this table: Table 1 Classes of recommendations View this table: Table 2 Levels of evidence The experts of the writing panels have provided disclosure statements of all relationships they may have that might be perceived as real or potential sources of conflicts of interest. These disclosure forms are kept on file at the European Heart House, headquarters of the ESC. Any changes in conflict of interest that arise during the writing period must be notified to the ESC. The Task Force report received its entire financial support from …
Published: 2010

15. ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

Author: Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Storey RF, Wood D, ESC Committee for Practice Guidelines 2008–2010, 2010–2012 Committees, Bax J, Vahanian A, Auricchio A, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Filippatos G, Funck Brentano C, Hasdai D, Hoes A, Kearney P, Knuuti J, Kolh P, McDonagh T, Moulin C, Poldermans D, Popescu BA, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vardas P, Widimsky P, Windecker S, Document Reviewers, Berkenboom G, De Graaf J, Descamps O, Gotcheva N, Griffith K, Guida GF, Gulec S, Henkin Y, Huber K, Kesaniemi YA, Lekakis J, Manolis AJ, Marques Vidal P, Masana L, McMurray J, Mendes M, Pagava Z, Pedersen T, Prescott E, Rato Q, Rosano G, Sans S, Stalenhoef A, Tokgozoglu L, Viigimaa M, Wittekoek ME, Zamorano J.L., PERRONE FILARDI, PASQUALE, RICCARDI, GABRIELE, Reiner, Z, Catapano, Al, De Backer, G, Graham, I, Taskinen, Mr, Wiklund, O, Agewall, S, Alegria, E, Chapman, Mj, Durrington, P, Erdine, S, Halcox, J, Hobbs, R, Kjekshus, J, PERRONE FILARDI, Pasquale, Riccardi, Gabriele, Storey, Rf, Wood, D, ESC Committee for Practice Guidelines, 2008–2010, 2010–2012, Committee, Bax, J, Vahanian, A, Auricchio, A, Baumgartner, H, Ceconi, C, Dean, V, Deaton, C, Fagard, R, Filippatos, G, Funck Brentano, C, Hasdai, D, Hoes, A, Kearney, P, Knuuti, J, Kolh, P, Mcdonagh, T, Moulin, C, Poldermans, D, Popescu, Ba, Sechtem, U, Sirnes, Pa, Tendera, M, Torbicki, A, Vardas, P, Widimsky, P, Windecker, S, Document, Reviewers, Berkenboom, G, De Graaf, J, Descamps, O, Gotcheva, N, Griffith, K, Guida, Gf, Gulec, S, Henkin, Y, Huber, K, Kesaniemi, Ya, Lekakis, J, Manolis, Aj, Marques Vidal, P, Masana, L, Mcmurray, J, Mendes, M, Pagava, Z, Pedersen, T, Prescott, E, Rato, Q, Rosano, G, Sans, S, Stalenhoef, A, Tokgozoglu, L, Viigimaa, M, Wittekoek, Me, Zamorano, J. L., Alberico L., Catapano, Željko, Reiner, Guy De, Backer, Ian, Graham, Marja Riitta, Taskinen, Olov, Wiklund, Stefan, Agewall, Eduardo, Alegria, M., John Chapman, Paul, Durrington, Serap, Erdine, Julian, Halcox, Richard, Hobb, John, Kjekshu, Robert F., Storey, and David, Wood
Subjects: Male, Nice, Type 2 diabetes, Disease, Coronary artery disease, Risk Factors, Health care, Secondary Prevention, Child, Societies, Medical, media_common, computer.programming_language, Hypolipidemic Agents, Clinical Trials as Topic, Middle Aged, Lipids, Europe, Primary Prevention, Cholesterol, Cardiovascular Diseases, Practice Guidelines as Topic, Female, Cardiology and Cardiovascular Medicine, Risk assessment, Risk, Adult, medicine.medical_specialty, Adolescent, Genotype, Lipoproteins, Advisory Committees, Cardiology, Guidelines as Topic, Risk Assessment, Specimen Handling, Sex Factors, Internal medicine, Weight Loss, medicine, media_common.cataloged_instance, Humans, cardiovascular diseases, European union, Intensive care medicine, Exercise, Life Style, Health aging / healthy living Cardiovascular diseases [IGMD 5], Aged, Dyslipidemias, Transplantation, business.industry, Guideline, medicine.disease, Atherosclerosis, Lipid Metabolism, Dietary Fats, Diet, Endocrinology, Early Diagnosis, Dietary Supplements, Kidney Failure, Chronic, Patient Compliance, business, Energy Intake, computer, Lipoprotein(a)
Abstract: Item does not contain fulltext Cardiovascular disease (CVD) due to atherosclerosis of the arterial vessel wall and to thrombosis is the foremost cause of premature mortality and of disability-adjusted life years (DALYs) in Europe, and is also increasingly common in developing countries.1 In the European Union, the economic cost of CVD represents annually E192 billion1 in direct and indirect healthcare costs. The main clinical entities are coronary artery disease (CAD), ischaemic stroke, and peripheral arterial disease (PAD). The causes of these CVDs are multifactorial. Some of these factors relate to lifestyles, such as tobacco smoking, lack of physical activity, and dietary habits, and are thus modifiable. Other risk factors are also modifiable, such as elevated blood pressure, type 2 diabetes, and dyslipidaemias, or non-modifiable, such as age and male gender. These guidelines deal with the management of dyslipidaemias as an essential and integral part of CVD prevention. Prevention and treatment of dyslipidaemias should always be considered within the broader framework of CVD prevention, which is addressed in guidelines of the Joint European Societies' Task forces on CVD prevention in clinical practice.2 - 5 The latest version of these guidelines was published in 20075; an update will become available in 2012. These Joint ESC/European Atherosclerosis Society (EAS) guidelines on the management of dyslipidaemias are complementary to the guidelines on CVD prevention in clinical practice and address not only physicians [e.g. general practitioners (GPs) and cardiologists] interested in CVD prevention, but also specialists from lipid clinics or metabolic units who are dealing with dyslipidaemias that are more difficult to classify and treat.
Published: 2011
Full Text: View/download PDF

16. ESC Guidelines on the management of cardiovascular diseases during pregnancy

Author: European Society of Gynecology, Association for European Paediatric Cardiology, German Society for Gender Medicine, Authors/Task Force Members, Regitz Zagrosek V., Blomstrom Lundqvist C., Cifkova R., Ferreira R., Foidart J. M., Gibbs J. S., Gohlke Baerwolf C., Gorenek B., Iung B., Kirby M., Maas A. H., Morais J., Nihoyannopoulos P., Pieper P. G., Presbitero P., Roos Hesselink J. W., Schaufelberger M., Seeland U., Torracca L, ESC Committee for Practice Guidelines, Bax J., Auricchio A., Baumgartner H., Ceconi C., Dean V., Deaton C., Fagard R., Funck Brentano C., Hasdai D., Hoes A., Knuuti J., Kolh P., McDonagh T., Moulin C., Poldermans D., Popescu B. A., Reiner Z., Sechtem U., Sirnes P. A., Torbicki A., Vahanian A., Windecker S., Document Reviewers, Aguiar C., Al Attar N., Garcia A. A., Antoniou A., Coman I., Elkayam U., Gomez Sanchez M. A., Gotcheva N., Hilfiker Kleiner D., Kiss R. G., Kitsiou A., Konings K. T., Lip G. Y., Manolis A., Mebaaza A., Mintale I., Morice M. C., Mulder B. J., Pasquet A., Price S., Priori S. G., Salvador M. J., Shotan A., Silversides C. K., Skouby S. O., Stein J. I., Tornos P., Vejlstrup N., Walker F., Warnes C., BORGHI, CLAUDIO, European Society of Gynecology, Association for European Paediatric Cardiology, German Society for Gender Medicine, Authors/Task Force Members, Regitz-Zagrosek V., Blomstrom Lundqvist C., Borghi C., Cifkova R., Ferreira R., Foidart J.M., Gibbs J.S., Gohlke-Baerwolf C., Gorenek B., Iung B., Kirby M., Maas A.H., Morais J., Nihoyannopoulos P., Pieper P.G., Presbitero P., Roos-Hesselink J.W., Schaufelberger M., Seeland U., Torracca L, ESC Committee for Practice Guidelines, Bax J., Auricchio A., Baumgartner H., Ceconi C., Dean V., Deaton C., Fagard R., Funck-Brentano C., Hasdai D., Hoes A., Knuuti J., Kolh P., McDonagh T., Moulin C., Poldermans D., Popescu B.A., Reiner Z., Sechtem U., Sirnes P.A., Torbicki A., Vahanian A., Windecker S., and Document Reviewers, Baumgartner H., Deaton C., Aguiar C., Al-Attar N., Garcia A.A., Antoniou A., Coman I., Elkayam U., Gomez-Sanchez M.A., Gotcheva N., Hilfiker-Kleiner D., Kiss R.G., Kitsiou A., Konings K.T., Lip G.Y., Manolis A., Mebaaza A., Mintale I., Morice M.C., Mulder B.J., Pasquet A., Price S., Priori S.G., Salvador M.J., Shotan A., Silversides C.K., Skouby S.O., Stein J.I., Tornos P., Vejlstrup N., Walker F., Warnes C.
Subjects: Counseling, Prenatal Diagnosi, Pregnancy Complications, Cardiovascular, Heart failure, Abortion, Induced, Prenatal Care, Venous Thromboembolism, Guideline, Cardiovascular disease, Aortic Disease, Valvular heart disease, Management, Congential heart disease, Heart Disease, Cardiovascular Agent, Pregnancy, Hypertension, Pregnancy Complications, Infectiou, Female, Cardiology and Cardiovascular Medicine, Arrhythmia, Risk assessment, Human
Abstract: not available
Published: 2011

17. Guidelines for the diagnosis and management of syncope (version 2009): the Task Force for the diagnosis and management of syncope of the European Society of Cardiology (ESC)

Author: European Heart Rhythm Association, Heart Failure Association, Heart Rhythm Society, European Society of Emergency Medicine, European Federation of Internal Medicine, European Union Geriatric Medicine Society, American Geriatrics Society, European Neurological Society, European Federation of Autonomic Societies, American Autonomic Society, Moya A., Sutton R., Ammirati F., Blanc J. J., Brignole M., Dham J. B., Deharo J. C., Gajek J., Gjesdal K., Krahn A., Massin M., Pepi M., Pezawas T., Granell R. R., Sarasin F., Ungar A., van DijK J. G., Walma E. P., Wieling W., Abe H., Benditt D. G., Decker W. W., Grubb B. P., Kaufmann H., Morillo C., Olshansky B., Parry S. W., Sheldon R., Shen W. K., ESC Committee for Practice Guidelines, Vahanian A., Auricchio A., Bax J., Ceconi C., Dean V., Filippatos G., Funck Brentano C., Hobbs R., Kearney P., McDonagh T., McGregor K., Popescu B. A., Reiner Z., Sechtem U., Sirnes P. A., Tendera M., Vardas P., Widimsky P., Acarturk E., Andreotti F., Asteggiano R., Bauersfeld U., Bellou A., Benetos A., Brandt J., Chung M. K., da Costa A., Extramiana F., Ferro J., Gorenek B., Hedman A., Hirsch R., Kaliska G., Kenny R. A., Kjeldsen K. P., Lampert R., Molgard H., Paju R., Puodziukynas A., Raviele A., Roman P., Scherer M., Schondorf R., Sicari R., Vanbrabant P., Wolpert C., Zamorano J. L., CORTELLI, PIETRO, European Heart Rhythm Association (EHRA), Heart Failure Association (HFA), Heart Rhythm Society (HRS), European Society of Emergency Medicine (EuSEM), European Federation of Internal Medicine (EFIM), European Union Geriatric Medicine Society (EUGMS), American Geriatrics Society (AGS), European Neurological Society (ENS), European Federation of Autonomic Societies (EFAS), American Autonomic Society (AAS), Moya A., Sutton R., Ammirati F., Blanc J.J., Brignole M., Dham J.B., Deharo J.C., Gajek J., Gjesdal K., Krahn A., Massin M., Pepi M., Pezawas T., Granell R.R., Sarasin F., Ungar A., van DijK J.G., Walma E.P., Wieling W., Abe H., Benditt D.G., Decker W.W., Grubb B.P., Kaufmann H., Morillo C., Olshansky B., Parry S.W., Sheldon R., Shen W.K., ESC Committee for Practice Guidelines (CPG), Vahanian A., Auricchio A., Bax J., Ceconi C., Dean V., Filippatos G., Funck-Brentano C., Hobbs R., Kearney P., McDonagh T., McGregor K., Popescu B.A., Reiner Z., Sechtem U., Sirnes P.A., Tendera M., Vardas P., Widimsky P., Acarturk E., Andreotti F., Asteggiano R., Bauersfeld U., Bellou A., Benetos A., Brandt J., Chung M.K., Cortelli P., da Costa A., Extramiana F., Ferro J., Gorenek B., Hedman A., Hirsch R., Kaliska G., Kenny R.A., Kjeldsen K.P., Lampert R., Molgard H., Paju R., Puodziukynas A., Raviele A., Roman P., Scherer M., Schondorf R., Sicari R., Vanbrabant P., Wolpert C., and Zamorano J.L.
Subjects: medicine.medical_specialty, media_common.quotation_subject, MEDLINE, Diagnostic Techniques, Neurological, Risk Assessment, Syncope, Age Distribution, Quality of life (healthcare), Cost of Illness, Ambulatory care, Recurrence, Risk Factors, Tilt-Table Test, Internal medicine, Ambulatory Care, Prevalence, Humans, Medicine, Quality (business), Referral and Consultation, media_common, business.industry, Conflict of interest, Evidence-based medicine, Continuity of Patient Care, Exercise Test, Quality of Life, Cardiology, Table (database), Esc Guidelines, Cardiology and Cardiovascular Medicine, business, Risk assessment
Abstract: Guidelines and Expert Consensus Documents summarize and evaluate all currently available evidence on a particular issue with the aim of assisting physicians in selecting the best management strategies for a typical patient, suffering from a given condition, taking into account the impact on outcome, as well as the risk/benefit ratio of particular diagnostic or therapeutic means. Guidelines are no substitutes for textbooks. The legal implications of medical guidelines have been previously discussed. A great number of Guidelines and Expert Consensus Documents have been issued in recent years by the European Society of Cardiology (ESC) as well as by other societies and organizations. Because of the impact on clinical practice, quality criteria for the development of guidelines have been established in order to make all decisions transparent to the user. The recommendations for formulating and issuing ESC Guidelines and Expert Consensus Documents can be found on the ESC Web Site (http://www.escardio.org/guidelines). In brief, experts in the field are selected and undertake a comprehensive review of the published evidence for management and/or prevention of a given condition. A critical evaluation of diagnostic and therapeutic procedures is performed, including assessment of the risk/benefit ratio. Estimates of expected health outcomes for larger societies are included, where data exist. The level of evidence and the strength of recommendation of particular treatment options are weighed and graded according to predefined scales, as outlined in Tables 1 and 2 . View this table: Table 1 Classes of recommendations View this table: Table 2 Levels of evidence The experts of the writing panels have provided disclosure statements of all relationships they may have which might be perceived as real or potential sources of conflicts of interest. These disclosure forms are kept on file at the European Heart House Headquarters of the ESC. Any changes in conflict of interest that arise during the writing period must be notified …
Published: 2009

18. 2014 ESC/ESA Guidelines on non-cardiac surgery : cardiovascular assessment and management : the Joint Task Force on non-cardiac surgery : cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).

Author: ESC Committee for Practice Guidelines, ESA Clinical Guidelines Committee, Kristensen, S. D., Pibarot, Philippe, Knuuti, Juhani, Saraste, Antti, Anker, Stefan D., Bøtker, Hans Erik, Hert, Stefan de, Ford, Ian, Gonzalez-Juanatey, José Ramón, Gorenek, Bulent, Heyndrickx, Guy R., Hoeft, Andreas, Huber, Kurt, Iung, Bernard, Kjeldsen, Keld, Longrois, Dan, Lüscher, Thomas F. (Thomas Felix), Piérard, Luc A., Pocock, Stuart J., Price, Susanna, Roffi, Marco, Sirnes, Per Anton, Sousa-Uva, Miguel, Voudris, Vassilis A., ESC Committee for Practice Guidelines, ESA Clinical Guidelines Committee, Kristensen, S. D., Pibarot, Philippe, Knuuti, Juhani, Saraste, Antti, Anker, Stefan D., Bøtker, Hans Erik, Hert, Stefan de, Ford, Ian, Gonzalez-Juanatey, José Ramón, Gorenek, Bulent, Heyndrickx, Guy R., Hoeft, Andreas, Huber, Kurt, Iung, Bernard, Kjeldsen, Keld, Longrois, Dan, Lüscher, Thomas F. (Thomas Felix), Piérard, Luc A., Pocock, Stuart J., Price, Susanna, Roffi, Marco, Sirnes, Per Anton, Sousa-Uva, Miguel, and Voudris, Vassilis A.
Published: 2016

19. 2014 ESC/EACTS Guidelines on myocardial revascularization. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Author: S. Windecker, P. Kolh, F. Alfonso, J. P. Collet, J. Cremer, V. Falk, G. Filippatos, C. Hamm, S. J. Head, P. Juni, A. P. Kappetein, A. Kastrati, J. Knuuti, U. Landmesser, G. Laufer, F. J. Neumann, D. J. Richter, P. Schauerte, M. Sousa Uva, G. G. Stefanini, D. P. Taggart, L. Torracca, M. Valgimigli, W. Wijns, A. Witkowski, ESC Committee for Practice Guidelines, J. L. Zamorano, S. Achenbach, H. Baumgartner, J. J. Bax, H. Bueno, V. Dean, C. Deaton, C. Erol, R. Fagard, R. Ferrari, D. Hasdai, A. W. Hoes, P. Kirchhof, P. Lancellotti, A. Linhart, P. Nihoyannopoulos, M. F. Piepoli, P. Ponikowski, P. A. Sirnes, J. L. Tamargo, M. Tendera, A. Torbicki, EACTS Clinical Guidelines Committee, Document reviewers, J. Pepper, A. Anyanwu, L. Badimon, J. Bauersachs, A. Baumbach, F. Beygui, N. Bonaros, M. De Carlo, D. Dobrev, J. Dunning, E. Eeckhout, S. Gielen, H. Luckraz, H. Mahrholdt, G. Montalescot, D. Paparella, A. J. Rastan, M. Sanmartin, P. Sergeant, S. Silber, J. Tamargo, J. ten Berg, H. Thiele, R. J. van Geuns, H. O. Wagner, S. Wassmann, O. Wendler, F. Weidinger, F. Ibrahimov, V. Legrand, I. Terzi, A. Postadzhiyan, B. Skoric, G. M. Georgiou, M. Zelizko, A. Junker, J. Eha, H. Romppanen, J. L. Bonnet, A. Aladashvili, R. Hambrecht, D. Becker, T. Gudnason, A. Segev, O. Sakhov, A. Mirrakhimov, B. Pereira, H. Felice, T. Trovik, D. Dudek, H. Pereira, M. A. Nedeljkovic, M. Hudec, A. Cequier, D. Erlinge, M. Roffi, S. Kedev, F. Addad, A. Yildirir, J. Davies, BUGIARDINI, RAFFAELE, Dobrev, Dobromir (Beitragende*r), University of Zurich, Windecker, Stephan, S. Windecker, P. Kolh, F. Alfonso, J.-P. Collet, J. Cremer, V. Falk, G. Filippato, C. Hamm, S. J. Head, P. Juni, A. P. Kappetein, A. Kastrati, J. Knuuti, U. Landmesser, G. Laufer, F.-J. Neumann, D. J. Richter, P. Schauerte, M. Sousa Uva, G. G. Stefanini, D. P. Taggart, L. Torracca, M. Valgimigli, W. Wijn, A. Witkowski, ESC Committee for Practice Guideline, J. L. Zamorano, S. Achenbach, H. Baumgartner, J. J. Bax, H. Bueno, V. Dean, C. Deaton, C. Erol, R. Fagard, R. Ferrari, D. Hasdai, A. W. Hoe, P. Kirchhof, P. Lancellotti, A. Linhart, P. Nihoyannopoulo, M. F. Piepoli, P. Ponikowski, P. A. Sirne, J. L. Tamargo, M. Tendera, A. Torbicki, EACTS Clinical Guidelines Committee, Document reviewer, J. Pepper, A. Anyanwu, L. Badimon, J. Bauersach, A. Baumbach, F. Beygui, N. Bonaro, M. De Carlo, D. Dobrev, J. Dunning, E. Eeckhout, S. Gielen, H. Luckraz, H. Mahrholdt, G. Montalescot, D. Paparella, A. J. Rastan, M. Sanmartin, P. Sergeant, S. Silber, J. Tamargo, J. ten Berg, H. Thiele, R.-J. van Geun, H.-O. Wagner, S. Wassmann, O. Wendler, F. Weidinger, F. Ibrahimov, V. Legrand, I. Terzi, A. Postadzhiyan, B. Skoric, G. M. Georgiou, M. Zelizko, A. Junker, J. Eha, H. Romppanen, J.-L. Bonnet, A. Aladashvili, R. Hambrecht, D. Becker, T. Gudnason, A. Segev, R. Bugiardini, O. Sakhov, A. Mirrakhimov, B. Pereira, H. Felice, T. Trovik, D. Dudek, H. Pereira, M. A. Nedeljkovic, M. Hudec, A. Cequier, D. Erlinge, M. Roffi, S. Kedev, F. Addad, A. Yildirir, and J. Davies
Subjects: Carotid Artery Diseases, Graft Rejection, Reoperation, Diabetic Cardiomyopathies, Decision Making, Heart Valve Diseases, Myocardial Infarction, Medizin, Contrast Media, Coronary Disease, 610 Medicine & health, Guideline, Myocardial ischaemia, Risk Assessment, 2705 Cardiology and Cardiovascular Medicine, Percutaneous coronary intervention, Peripheral Arterial Disease, Fibrinolytic Agents, Patient Education as Topic, 360 Social problems & social services, Humans, Hypoglycemic Agents, Blood Transfusion, Drug Interactions, Thrombolytic Therapy, Coronary Artery Bypass, Renal Insufficiency, Chronic, Heart Failure, Patient Care Team, ta3126, Informed Consent, ACUTE CORONARY SYNDROMES, Bare-metal stent, Anticoagulants, Arrhythmias, Cardiac, ta3121, 10020 Clinic for Cardiac Surgery, Cardiac Imaging Techniques, Myocardial revascularization, Chronic Disease, Purinergic P2Y Receptor Antagonists, CORONARY ARTERY DISEASE, Stents, Heart-Assist Devices, Drug-eluting stent, Cardiology and Cardiovascular Medicine
Abstract: No abstract available - Guidelines
Published: 2014
Full Text: View/download PDF

20. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation * Developed with the special contribution of the European Heart Rhythm Association

Author: Camm, Aj, Lip, Gy, De Caterina, R, Savelieva, I, Atar, D, Hohnloser, Sh, Hindricks, G, Kirchhof, P, ESC Committee for Practice Guidelines, Bax, Jj, Baumgartner, H, Ceconi, Claudio, Dean, V, Deaton, C, Fagard, R, Funck Brentano, C, Hasdai, D, Hoes, A, Knuuti, J, Kolh, P, Mcdonagh, T, Moulin, C, Popescu, Ba, Reiner, Z, Sechtem, U, Sirnes, Pa, Tendera, M, Torbicki, A, Vahanian, A, Windecker, S, Document, Reviewers, Vardas, P, Al Attar, N, Alfieri, O, Angelini, A, Blömstrom Lundqvist, C, Colonna, P, De Sutter, J, Ernst, S, Goette, A, Gorenek, B, Hatala, R, Heidbüchel, H, Heldal, M, Kristensen, Sd, Le Heuzey JY, Mavrakis, H, Mont, L, Filardi, Pp, Ponikowski, P, Prendergast, B, Rutten, Fh, Schotten, U, Van Gelder IC, and Verheugt, F. W.
Subjects: Focused update, Rate control, Guidelines, Upstream therapy, Left atrial appendage occlusion, Atrial fibrillation, Pulmonary vein isolation, Left atrial ablation, Antiarrhythmic drugs, European Society of Cardiology, Cardioversion, Anticoagulation, Rhythm control, Novel oral anticoagulants
Published: 2012

21. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)

Author: Vahanian, A, Alfieri, O, Andreotti, F, Antunes, Mj, Barón Esquivias, G, Baumgartner, H, Borger, Ma, Carrel, Tp, De Bonis, M, Evangelista, A, Falk, V, Iung, B, Lancellotti, P, Pierard, L, Price, S, Schäfers, Hj, Schuler, G, Stepinska, J, Swedberg, K, Takkenberg, J, Von Oppell UO, Windecker, S, Zamorano, Jl, Zembala, M, ESC Committee for Practice Guidelines, Bax, Jj, Ceconi, Claudio, Dean, V, Deaton, C, Fagard, R, Funck Brentano, C, Hasdai, D, Hoes, A, Kirchhof, P, Knuuti, J, Kolh, P, Mcdonagh, T, Moulin, C, Popescu, Ba, Reiner, Z, Sechtem, U, Sirnes, Pa, Tendera, M, Torbicki, A, Document, Reviewers, Von Segesser, L, Badano, Lp, Bunc, M, Claeys, Mj, Drinkovic, N, Filippatos, G, Habib, G, Kappetein, Ap, Kassab, R, Lip, Gy, Moat, N, Nickenig, G, Otto, Cm, Pepper, J, Piazza, N, Pieper, Pg, Rosenhek, R, Shuka, N, Schwammenthal, E, Schwitter, J, Mas, Pt, Trindade, Pt, and Walther, T.
Subjects: NO
Published: 2012

22. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

Author: Steg, Pg, James, Sk, Atar, D, Badano, Lp, Lundqvist, Cb, Borger, Ma, Di Mario, C, Dickstein, K, Ducrocq, G, Fernandez Aviles, F, Gershlick, Ah, Giannuzzi, P, Halvorsen, S, Huber, K, Juni, P, Kastrati, A, Knuuti, J, Lenzen, Mj, Mahaffey, Kw, Valgimigli, M, Van't Hof, A, Widimsky, P, Zahger, D, ESC Committee for Practice Guidelines, Bax, Jj, Baumgartner, H, Ceconi, Claudio, Dean, V, Deaton, C, Fagard, R, Funck Brentano, C, Hasdai, D, Hoes, A, Kirchhof, P, Kolh, P, Mcdonagh, T, Moulin, C, Popescu, Ba, Reiner, Z, Sechtem, U, Sirnes, Pa, Tendera, M, Torbicki, A, Vahanian, A, Windecker, S, Document, Reviewers, Astin, F, Aström Olsson, K, Budaj, A, Clemmensen, P, Collet, Jp, Fox, Ka, Fuat, A, Gustiene, O, Hamm, Cw, Kala, P, Lancellotti, P, Maggioni, Ap, Merkely, B, Neumann, Fj, Piepoli, Mf, Van de Werf, F, Verheugt, F, Wallentin, L., Steg, P, James, S, Atar, D, Badano, L, Lundqvist, C, Borger, M, Di Mario, C, Dickstein, K, Ducrocq, G, Fernandez-Aviles, F, Gershlick, A, Giannuzzi, P, Halvorsen, S, Huber, K, Juni, P, Kastrati, A, Knuuti, J, Lenzen, M, Mahaffey, K, Valgimigli, M, Van'T Hof, A, Widimsky, P, Zahger, D, Bax, J, Baumgartner, H, Ceconi, C, Dean, V, Deaton, C, Fagard, R, Funck-Brentano, C, Hasdai, D, Hoes, A, Kirchhof, P, Kolh, P, Mcdonagh, T, Moulin, C, Popescu, B, Reiner, Z, Sechtem, U, Sirnes, P, Tendera, M, Torbicki, A, Vahanian, A, Windecker, S, Astin, F, Astrom-Olsson, K, Budaj, A, Clemmensen, P, Collet, J, Fox, K, Fuat, A, Gustiene, O, Hamm, C, Kala, P, Lancellotti, P, Maggioni, A, Merkely, B, Neumann, F, Piepoli, M, Van De Werf, F, Verheugt, F, and Wallentin, L
Subjects: Emergency Medical Services, Biomedical Research, General Practice, Myocardial Infarction, Guideline, Anxiety, ST-segment elevation, Electrocardiography, Myocardial infarction, Coronary Artery Bypass, 610 Medicine & health, Fibrinolytic Agent, Cardiovascular diseases [NCEBP 14], Secondary prevention, General Medicine, Reperfusion therapy, Antifibrinolytic Agents, Exercise Therapy, Hospitalization, cardiovascular system, Cardiology, Acute coronary syndromes Ischaemic heart disease, Cardiomyopathies, Cardiology and Cardiovascular Medicine, Ticagrelor, Human, medicine.drug, Acute coronary syndrome, medicine.medical_specialty, Cardiotonic Agents, Pain, Myocardial Reperfusion, Acute myocardial infarction, Guidelines, Antifibrinolytic Agent, Risk Assessment, Time-to-Treatment, Percutaneous Coronary Intervention, Fibrinolytic Agents, Internal medicine, medicine, Humans, Cardiotonic Agent, Hemodynamic, cardiovascular diseases, Emergency Treatment, Cardiomyopathie, Heart Failure, Cardiac Imaging Technique, Management of acute coronary syndrome, Emergency Medical Service, business.industry, Coronary Artery Bypa, Platelet Aggregation Inhibitor, Hemodynamics, Arrhythmias, Cardiac, MED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLARE, medicine.disease, Long-Term Care, Primary percutaneous coronary intervention Antithrombotic therapy, Cardiac Imaging Techniques, Dyspnea, Hyperglycemia, Door-to-balloon, Myocardial infarction complications, Myocardial infarction diagnosis, business, Risk Reduction Behavior, Platelet Aggregation Inhibitors, Out-of-Hospital Cardiac Arrest, Forecasting
Abstract: ACE : angiotensin-converting enzyme ACS : acute coronary syndrome ADP : adenosine diphosphate AF : atrial fibrillation AMI : acute myocardial infarction AV : atrioventricular AIDA-4 : Abciximab Intracoronary vs. intravenously Drug Application APACHE II : Acute Physiology Aand Chronic
Published: 2012
Full Text: View/download PDF

23. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation * Developed with the special contribution of the European Heart Rhythm Association

Author: Camm, A John, Lip, Gregory Y H, De Caterina, Raffaele, Savelieva, Irene, Atar, Dan, Hohnloser, Stefan H, Hindricks, Gerhard, Kirchhof, Paulus, ESC Committee for Practice Guidelines, CPG, Bax, Jeroen J, Baumgartner, Helmut, Ceconi, Claudio, Dean, Veronica, Deaton, Christi, Fagard, Robert, Funck-Brentano, Christian, Hasdai, David, Hoes, Arno, Knuuti, Juhani, Kolh, Philippe, McDonagh, Theresa, Moulin, Cyril, Popescu, Bogdan A, Reiner, Zeljko, Sechtem, Udo, Sirnes, Per Anton, Tendera, Michal, Torbicki, Adam, Vahanian, Alec, Windecker, Stephan, Vardas, Panos, Al-Attar, Nawwar, Alfieri, Ottavio, Angelini, Annalisa, Blömstrom-Lundqvist, Carina, Colonna, Paolo, De Sutter, Johan, Ernst, Sabine, Goette, Andreas, Gorenek, Bulent, Hatala, Robert, Heidbüchel, Hein, Heldal, Magnus, Kristensen, Steen Dalby, Le Heuzey, Jean-Yves, Mavrakis, Hercules, Mont, Lluís, Filardi, Pasquale Perrone, Ponikowski, Piotr, Prendergast, Bernard, Rutten, Frans H, Schotten, Ulrich, Van Gelder, Isabelle C, Verheugt, Freek W A, Camm, Aj, Lip, Gy, De Caterina, R, Savelieva, I, Atar, D, Hohnloser, Sh, Hindricks, G, Kirchhof, P, ESC Committee for Practice, Guideline, Bax, Jj, Baumgartner, H, Ceconi, C, Dean, V, Deaton, C, Fagard, R, Funck Brentano, C, Hasdai, D, Hoes, A, Knuuti, J, Kolh, P, Mcdonagh, T, Moulin, C, Popescu, Ba, Reiner, Z, Sechtem, U, Sirnes, Pa, Tendera, M, Torbicki, A, Vahanian, A, Windecker, S, Vardas, P, Al Attar, N, Alfieri, O, Angelini, A, Blömstrom Lundqvist, C, Colonna, P, De Sutter, J, Ernst, S, Goette, A, Gorenek, B, Hatala, R, Heidbüchel, H, Heldal, M, Kristensen, Sd, Le Heuzey, Jy, Mavrakis, H, Mont, L, PERRONE FILARDI, Pasquale, Ponikowski, P, Prendergast, B, Rutten, Fh, Schotten, U, Van Gelder, Ic, and Verheugt, F. W.
Published: 2012
Full Text: View/download PDF

24. European guidelines on cardiovascular disease prevention in clinical practice (version 2012) : the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)

Author: Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Z., Verschuren, M., Albus, C., Benlian, P., Boysen, G., Cifkova, R., Deaton, C., Ebrahim, S., Fisher, M., Germano, G., Hobbs, R., Hoes, A., Karadeniz, S., Mezzani, A., Prescott, E., Ryden, L., Scherer, M., Syvanne, M., Scholte Op Reimer, W. J. M., Vrints, C., Wood, D., Zamorano, J. L., Zannad, F., Cooney, M. T., Bax, J., Baumgartner, H., Ceconi, C., Dean, V., Fagard, R., Funck Brentano, C., Hasdai, D., Kirchhof, P., Knuuti, J., Kolh, P., Mcdonagh, T., Moulin, C., Popescu, B. A., Sechtem, U., Sirnes, P. A., Tendera, M., Torbicki, A., Vahanian, A., Windecker, S., Aboyans, V., Ezquerra, E. A., Baigent, C., Brotons, C., Burell, G., Ceriello, A., De Sutter, J., Deckers, J., Del Prato, S., Diener, H. C., Fitzsimons, D., Fras, Z., Hambrecht, R., Jankowski, P., Keil, U., Kirby, M., Larsen, M. L., Mancia, G., Manolis, A. J., Mcmurray, J., Pajak, A., Parkhomenko, A., Rallidis, L., Rigo, F., Rocha, E., Ruilope, L. M., Van Der Velde, E., Vanuzzo, D., Viigimaa, M., Volpe, Massimo, Wiklund, O., Wolpert, C., Authors/task Force Members, Parts Of The Guidelines:, Other Experts Who Contributed T. O., Esc, Committee For Practice Guidelines :., Document, Reviewers, School of Health and Caring Sciences, Linnaeus University, Department of Public Health, University of Gent, University Hospital Center Zagreb, 2nd Department of Internal Medicine, Faculty of Epidemiology and Population Health [London], London School of Hygiene and Tropical Medicine (LSHTM), Primary Care Clinical Sciences, University of Birmingham [Birmingham], Service de Cardiologie [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Neuroépidémiologie Tropicale (NET), Institut Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST), and Université de Limoges (UNILIM)-Université de Limoges (UNILIM)-CHU Limoges-Institut d'Epidémiologie Neurologique et de Neurologie Tropicale-Institut National de la Santé et de la Recherche Médicale (INSERM)
Subjects: Male, Epidemiology, medicine.medical_treatment, General Practice, physical activity, Blood Pressure, Smoking Prevention, Comorbidity, prevention, Electronic Health Records, Myocardial infarction, ComputingMilieux_MISCELLANEOUS, education.field_of_study, Rehabilitation, Cardiac Rehabilitation, Evidence-Based Medicine, Prognosis, Cardiovascular disease, Lipids, Drug Combinations, nutrition, Cardiovascular Diseases, Cardiology and Cardiovascular Medicine, Diagnostic Imaging, medicine.medical_specialty, Hypercholesterolemia, Advisory Committees, Health Promotion, Risk Assessment, Medication Adherence, European guidelines, cardiovascular disease prevention, Humans, education, Physician's Role, Exercise, Life Style, Aged, Primary Health Care, Patient Selection, Cardiovascular Agents, medicine.disease, Self Care, Health promotion, Early Diagnosis, Diabetes Mellitus, Type 2, Cardiology, Disease prevention, Risk Reduction Behavior, Biomarkers, Diabetic Angiopathies, Systolic hypertension, Risk Factors, Preventive Health Services, Applied Psychology, Middle Aged, Clopidogrel, Clinical Practice, Hospitalization, Europe, Treatment Outcome, Heart Function Tests, Hypertension, Female, Heart Protection Study, medicine.drug, Adult, Consensus, United Kingdom Prospective Diabetes Study, Population, MEDLINE, psychosocial factors, risk assessment, risk management, smoking, Nurse's Role, Predictive Value of Tests, Internal medicine, medicine, Obesity, cardiovascular diseases, Antihypertensive Agents, Task force, business.industry, Percutaneous coronary intervention, Diet, Socioeconomic Factors, Family medicine, Heart failure, Chronic Disease, Smoking Cessation, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, business, Delivery of Health Care, Stress, Psychological, Kidney disease
Abstract: ABI : ankle–brachial index ACCORD : Action to Control Cardiovascular Risk in Diabetes ADVANCE : Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation AGREE : Appraisal of Guidelines Research and Evaluation AHA : American Heart Association apoA1 : apolipoprotein A1 apoB : apolipoprotein B CABG : coronary artery bypass graft surgery CARDS : Collaborative AtoRvastatin Diabetes Study CCNAP : Council on Cardiovascular Nursing and Allied Professions CHARISMA : Clopidogrel for High Athero-thrombotic Risk and Ischemic Stabilisation, Management, and Avoidance CHD : coronary heart disease CKD : chronic kidney disease COMMIT : Clopidogrel and Metoprolol in Myocardial Infarction Trial CRP : C-reactive protein CURE : Clopidogrel in Unstable Angina to Prevent Recurrent Events CVD : cardiovascular disease DALYs : disability-adjusted life years DBP : diastolic blood pressure DCCT : Diabetes Control and Complications Trial ED : erectile dysfunction eGFR : estimated glomerular filtration rate EHN : European Heart Network EPIC : European Prospective Investigation into Cancer and Nutrition EUROASPIRE : European Action on Secondary and Primary Prevention through Intervention to Reduce Events GFR : glomerular filtration rate GOSPEL : Global Secondary Prevention Strategies to Limit Event Recurrence After MI GRADE : Grading of Recommendations Assessment, Development and Evaluation HbA1c : glycated haemoglobin HDL : high-density lipoprotein HF-ACTION : Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing HOT : Hypertension Optimal Treatment Study HPS : Heart Protection Study HR : hazard ratio hsCRP : high-sensitivity C-reactive protein HYVET : Hypertension in the Very Elderly Trial ICD : International Classification of Diseases IMT : intima-media thickness INVEST : International Verapamil SR/Trandolapril JTF : Joint Task Force LDL : low-density lipoprotein Lp(a) : lipoprotein(a) LpPLA2 : lipoprotein-associated phospholipase 2 LVH : left ventricular hypertrophy MATCH : Management of Atherothrombosis with Clopidogrel in High-risk Patients with Recent Transient Ischaemic Attack or Ischaemic Stroke MDRD : Modification of Diet in Renal Disease MET : metabolic equivalent MONICA : Multinational MONItoring of trends and determinants in CArdiovascular disease NICE : National Institute of Health and Clinical Excellence NRT : nicotine replacement therapy NSTEMI : non-ST elevation myocardial infarction ONTARGET : Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial OSA : obstructive sleep apnoea PAD : peripheral artery disease PCI : percutaneous coronary intervention PROactive : Prospective Pioglitazone Clinical Trial in Macrovascular Events PWV : pulse wave velocity QOF : Quality and Outcomes Framework RCT : randomized clinical trial RR : relative risk SBP : systolic blood pressure SCORE : Systematic Coronary Risk Evaluation Project SEARCH : Study of the Effectiveness of Additional Reductions in Cholesterol and SHEP : Systolic Hypertension in the Elderly Program STEMI : ST-elevation myocardial infarction SU.FOL.OM3 : SUpplementation with FOlate, vitamin B6 and B12 and/or OMega-3 fatty acids Syst-Eur : Systolic Hypertension in Europe TNT : Treating to New Targets UKPDS : United Kingdom Prospective Diabetes Study VADT : Veterans Affairs Diabetes Trial VALUE : Valsartan Antihypertensive Long-term Use VITATOPS : VITAmins TO Prevent Stroke VLDL : very low-density lipoprotein WHO : World Health Organization ### 1.1 Introduction Atherosclerotic cardiovascular disease (CVD) is a chronic disorder developing insidiously throughout life and usually progressing to an advanced stage by the time symptoms occur. It remains the major cause of premature death in Europe, even though CVD mortality has …
Published: 2012
Full Text: View/download PDF

25. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)

Author: Authors, Task Force Members, Vahanian, Alec, Alfieri, Ottavio, Andreotti, Felicita, Antunes, Manuel J, Barón-Esquivias, Gonzalo, Baumgartner, Helmut, Borger, Michael Andrew, Carrel, Thierry P, De Bonis, Michele, Evangelista, Arturo, Falk, Volkmar, Lung, Bernard, Lancellotti, Patrizio, Pierard, Luc, Price, Susanna, Schäfers, Hans-Joachim, Schuler, Gerhard, Stepinska, Janina, Swedberg, Karl, Takkenberg, Johanna, Von Oppell, Ulrich Otto, Windecker, Stephan, Zamorano, Jose Luis, Zembala, Marian, ESC Committee for Practice Guidelines, CPG, Bax, Jeroen J, Ceconi, Claudio, Dean, Veronica, Deaton, Christi, Fagard, Robert, Funck-Brentano, Christian, Hasdai, David, Hoes, Arno, Kirchhof, Paulus, Knuuti, Juhani, Kolh, Philippe, McDonagh, Theresa, Moulin, Cyril, Popescu, Bogdan A, Reiner, Zeljko, Sechtem, Udo, Sirnes, Per Anton, Tendera, Michal, Torbicki, Adam, Document, Reviewers, Von Segesser, Ludwig, Badano, Luigi P, Bunc, Matjaz, Claeys, Marc J, Drinkovic, Niksa, Filippatos, Gerasimos, Habib, Gilbert, Kappetein, A Pieter, Kassab, Roland, Lip, Gregory Y H, Moat, Neil, Nickenig, Georg, Otto, Catherine M, Pepper, John, Piazza, Nicolo, Pieper, Petronella G, Rosenhek, Raphael, Shuka, Naltin, Schwammenthal, Ehud, Schwitter, Juerg, Mas, Pilar Tornos, Trindade, Pedro T, Walther, Thomas, Authors/Task Force, Member, Vahanian, A, Alfieri, Ottavio, Andreotti, F, Antunes, Mj, Baron Esquivias, G, Baumgartner, H, Borger, Ma, Carrel, Tp, DE BONIS, Michele, Evangelista, A, Falk, V, Iung, B, Lancellotti, P, Pierard, L, Price, S, Schafers, Hj, Schuler, G, Stepinska, J, Swedberg, K, Takkenberg, J, Von Oppell, Uo, Windecker, S, Zamorano, Jl, Zembala, M, ESC Committee for Practice, Guideline, Bax, Jj, Ceconi, C, Dean, V, Deaton, C, Fagard, R, Funck Brentano, C, Hasdai, D, Hoes, A, Kirchhof, P, Knuuti, J, Kolh, P, Mcdonagh, T, Moulin, C, Popescu, Ba, Reiner, Z, Sechtem, U, Sirnes, Pa, Tendera, M, Torbicki, A, Document, Reviewer, Von Segesser, L, Badano, Lp, Bunc, M, Claeys, Mj, Drinkovic, N, Filippatos, G, Habib, G, Kappetein, Ap, Kassab, R, Lip, Gy, Moat, N, Nickenig, G, Otto, Cm, Pepper, J, Piazza, N, Pieper, Pg, Rosenhek, R, Shuka, N, Schwammenthal, E, Schwitter, J, Mas, Pt, Trindade, Pt, and Walther, T.
Subjects: 610 Medicine & health
Published: 2012
Full Text: View/download PDF

26. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

Author: Mcmurray, Jj, Adamopoulos, S, Anker, Sd, Auricchio, A, Böhm, M, Dickstein, K, Falk, V, Filippatos, G, Fonseca, C, Gomez Sanchez MA, Jaarsma, T, Køber, L, Lip, Gy, Maggioni, Ap, Parkhomenko, A, Pieske, Bm, Popescu, Ba, Rønnevik, Pk, Rutten, Fh, Schwitter, J, Seferovic, P, Stepinska, J, Trindade, Pt, Voors, Aa, Zannad, F, Zeiher, A, Task Force for the Diagnosis, Treatment of Acute, Chronic Heart Failure 2012 of the European Society of Cardiology, Bax, Jj, Baumgartner, H, Ceconi, Claudio, Dean, V, Deaton, C, Fagard, R, Funck Brentano, C, Hasdai, D, Hoes, A, Kirchhof, P, Knuuti, J, Kolh, P, Mcdonagh, T, Moulin, C, Reiner, Z, Sechtem, U, Sirnes, Pa, Tendera, M, Torbicki, A, Vahanian, A, Windecker, S, Bonet, La, Avraamides, P, Ben Lamin HA, Brignole, M, Coca, A, Cowburn, P, Dargie, H, Elliott, P, Flachskampf, Fa, Guida, Gf, Hardman, S, Iung, B, Merkely, B, Mueller, C, Nanas, Jn, Nielsen, Ow, Orn, S, Parissis, Jt, Ponikowski, P, and ESC Committee for Practice Guidelines
Subjects: Beta-blockers, Ejection fraction, Transplantation, Digitalis, Heart failure, Natriuretic peptides, Reninangiotensin system, NO
Published: 2012

27. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC)

Author: Regitz Zagrosek, V, Blomstrom Lundqvist, C, Borghi, C, Cifkova, R, Ferreira, R, Foidart, Jm, Gibbs, Js, Gohlke Baerwolf, C, Gorenek, B, Iung, B, Kirby, M, Maas, Ah, Morais, J, Nihoyannopoulos, P, Pieper, Pg, Presbitero, P, Roos Hesselink JW, Schaufelberger, M, Seeland, U, Torracca, L, ESC Committee for Practice Guidelines, Bax, J, Auricchio, A, Baumgartner, H, Ceconi, Claudio, Dean, V, Deaton, C, Fagard, R, Funck Brentano, C, Hasdai, D, Hoes, A, Knuuti, J, Kolh, P, Mcdonagh, T, Moulin, C, Poldermans, D, Popescu, Ba, Reiner, Z, Sechtem, U, Sirnes, Pa, Torbicki, A, Vahanian, A, Windecker, S, Document, Reviewers, Aguiar, C, Al Attar, N, Garcia, Aa, Antoniou, A, Coman, I, Elkayam, U, Gomez Sanchez MA, Gotcheva, N, Hilfiker Kleiner, D, Kiss, Rg, Kitsiou, A, Konings, Kt, Lip, Gy, Manolis, A, Mebaaza, A, Mintale, I, Morice, Mc, Mulder, Bj, Pasquet, A, Price, S, Priori, Sg, Salvador, Mj, Shotan, A, Silversides, Ck, Skouby, So, Stein, Ji, Tornos, P, Vejlstrup, N, Walker, F, Warnes, C., ACS - Amsterdam Cardiovascular Sciences, and Cardiology
Subjects: Counseling, medicine.medical_specialty, Peripartum cardiomyopathy, Heart disease, Heart Diseases, Pregnancy Complications, Cardiovascular, Aortic Diseases, Coronary artery disease, Pregnancy, Internal medicine, Prenatal Diagnosis, Medicine, Humans, cardiovascular diseases, Pregnancy Complications, Infectious, Framingham Risk Score, business.industry, Contraindications, valvular heart disease, Atrial fibrillation, Abortion, Induced, Cardiovascular Agents, Prenatal Care, Venous Thromboembolism, medicine.disease, Heart failure, Cardiovascular agent, Hypertension, Cardiology, Female, Cardiology and Cardiovascular Medicine, business
Abstract: Table 1. Classes of recommendation Table 2. Levels of evidence Table 3. Estimated fetal and maternal effective doses for various diagnostic and interventional radiology procedures Table 4. Predictors of maternal cardiovascular events and risk score from the CARPREG study Table 5. Predictors of maternal cardiovascular events identified in congential heart diseases in the ZAHARA and Khairy study Table 6. Modified WHO classification of maternal cardiovascular risk: principles Table 7. Modified WHO classification of maternal cardiovascular risk: application Table 8. Maternal predictors of neonatal events in women with heart disease Table 9. General recommendations Table 10. Recommendations for the management of congenital heart disease Table 11. Recommendations for the management of aortic disease Table 12. Recommendations for the management of valvular heart disease Table 13. Recommendations for the management of coronary artery disease Table 14. Recommendations for the management of cardiomyopathies and heart failure Table 15. Recommendations for the management of arrhythmias Table 16. Recommendations for the management of hypertension Table 17. Check list for risk factors for venous thrombo-embolism Table 18. Prevalence of congenital thrombophilia and the associated risk of venous thrombo-embolism during pregnancy Table 19. Risk groups according to risk factors: definition and preventive measures Table 20. Recommendations for the prevention and management of venous thrombo-embolism in pregnancy and puerperium Table 21. Recommendations for drug use ABPM : ambulatory blood pressure monitoring ACC : American College of Cardiology ACE : angiotensin-converting enzyme ACS : acute coronary syndrome AF : atrial fibrillation AHA : American Heart Association aPTT : activated partial thromboplastin time ARB : angiotensin receptor blocker AS : aortic stenosis ASD : atrial septal defect AV : atrioventricular AVSD : atrioventricular septal defect BMI : body mass index BNP : B-type natriuretic peptide BP : blood pressure CDC : Centers for Disease Control CHADS : congestive heart failure, hypertension, age (>75 years), diabetes, stroke CI : confidence interval CO : cardiac output CoA : coarction of the aorta CT : computed tomography CVD : cardiovascular disease DBP : diastolic blood pressure DCM : dilated cardiomyopathy DVT : deep venous thrombosis ECG : electrocardiogram EF : ejection fraction ESC : European Society of Cardiology ESH : European Society of Hypertension ESICM : European Society of Intensive Care Medicine FDA : Food and Drug Administration HCM : hypertrophic cardiomyopathy ICD : implantable cardioverter-defibrillator INR : international normalized ratio i.v. : intravenous LMWH : low molecular weight heparin LV : left ventricular LVEF : left ventricular ejection fraction LVOTO : left ventricular outflow tract obstruction MRI : magnetic resonance imaging MS : mitral stenosis NT-proBNP : N-terminal pro B-type natriuretic peptide NYHA : New York Heart Association OAC : oral anticoagulant PAH : pulmonary arterial hypertension PAP : pulmonary artery pressure PCI : percutaneous coronary intervention PPCM : peripartum cardiomyopathy PS : pulmonary valve stenosis RV : right ventricular SBP : systolic blood pressure SVT : supraventricular tachycardia TGA : complete transposition of the great arteries TR : tricuspid regurgitation UFH : unfractionated heparin VSD : ventricular septal defect VT : ventricular tachycardia VTE : venous thrombo-embolism WHO : World Health Organization Guidelines summarize and evaluate all available evidence, at the time of the writing process, on a particular issue with the aim of assisting physicians in selecting the best management strategies for an individual patient, with a given condition, taking into account the impact on outcome, as well as the risk–benefit ratio of particular diagnostic or therapeutic means. Guidelines are no substitutes but are complements for textbooks and cover the European Society of Cardiology (ESC) Core Curriculum topics. Guidelines and recommendations should help the …
Published: 2011
Full Text: View/download PDF

28. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)

Author: Hamm, Cw, Bassand, Jp, Agewall, S, Bax, J, Boersma, E, Bueno, H, Caso, P, Dudek, D, Gielen, S, Huber, K, Ohman, M, Petrie, Mc, Sonntag, F, Uva, Ms, Storey, Rf, Wijns, W, Zahger, D, ESC Committee for Practice Guidelines, Bax, Jj, Auricchio, A, Baumgartner, H, Ceconi, Claudio, Dean, V, Deaton, C, Fagard, R, Funck Brentano, C, Hasdai, D, Hoes, A, Knuuti, J, Kolh, P, Mcdonagh, T, Moulin, C, Poldermans, D, Popescu, Ba, Reiner, Z, Sechtem, U, Sirnes, Pa, Torbicki, A, Vahanian, A, Windecker, S, Document, Reviewers, Achenbach, S, Badimon, L, Bertrand, M, Bøtker, He, Collet, Jp, Crea, F, Danchin, N, Falk, E, Goudevenos, J, Gulba, D, Hambrecht, R, Herrmann, J, Kastrati, A, Kjeldsen, K, Kristensen, Sd, Lancellotti, P, Mehilli, J, Merkely, B, Montalescot, G, Neumann, Fj, Neyses, L, Perk, J, Roffi, M, Romeo, F, Ruda, M, Swahn, E, Valgimigli, M, Vrints, Cj, Widimsky, P., and Neyses, Ludwig [collaborator]
Subjects: unstable angina, Male, Platelet Glycoprotein GPIIb-IIIa Complex/antagonists & inhibitors, Diabetic Cardiomyopathies, Platelet Aggregation Inhibitors/therapeutic use, heparin, Diagnostic Imaging/methods, Myocardial Revascularization, ST segment, Myocardial Revascularization/methods, guidelines, Angioplasty, Balloon, Coronary, Biological Markers/blood, Coronary Artery Bypass, Aged, 80 and over, Evidence-Based Medicine, diabetes, bivalirudin, troponin, Age Factors, Diabetic Cardiomyopathies/diagnosis/therapy, angioplasty, enoxaparin, Systèmes cardiovasculaire & respiratoire [D03] [Sciences de la santé humaine], Prognosis, Angioplasty, Balloon, Coronary/methods, Anticoagulants/therapeutic use, Cardiology, Biological Markers, Female, Cardiology and Cardiovascular Medicine, Physical Examination/methods, Diagnostic Imaging, medicine.medical_specialty, Cardiotonic Agents, aspirin, non-ST-elevation myocardial infarction, Hemorrhage, Platelet Glycoprotein GPIIb-IIIa Complex, Risk Assessment, Acute Coronary Syndrome/diagnosis/etiology/*therapy, acute coronary syndrome, European Society of Cardiology, ticagrelor, Diagnosis, Differential, Internal medicine, chest pain unit, medicine, Humans, In patient, Hemorrhage/etiology, Acute Coronary Syndrome, Physical Examination, Aged, clopidogrel, Management of acute coronary syndrome, Task force, business.industry, Acute Coronary Syndrome/diagnosis/etiology/therapy, fondaparinux, Elevation, Anticoagulants, Long-Term Care, Cardiotonic Agents/therapeutic use, prasugrel, bypass surgery, Settore MED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLARE, stent, Cardiovascular & respiratory systems [D03] [Human health sciences], business, Biomarkers, Biomarkers/blood, Platelet Aggregation Inhibitors
Abstract: Eur Heart J
Published: 2011
Full Text: View/download PDF

29. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)

Author: European Association, for Percutaneous Cardiovascular Interventions, Wijns, William, Kolh, Philippe, Danchin, Nicolas, Di Mario, Carlo, Falk, Volkmar, Folliguet, Thierry, Garg, Scot, Huber, Kurt, James, Stefan, Knuuti, Juhani, Lopez-Sendon, Jose, Marco, Jean, Menicanti, Lorenzo, Ostojic, Miodrag, Piepoli, Massimo F, Pirlet, Charles, Pomar, Jose L, Reifart, Nicolaus, Ribichini, Flavio L, Schalij, Martin J, Sergeant, Paul, Serruys, Patrick W, Silber, Sigmund, Sousa Uva, Miguel, Taggart, David, ESC Committee, for Practice Guidelines, Vahanian, Alec, Auricchio, Angelo, Bax, Jeroen, Ceconi, Claudio, Dean, Veronica, Filippatos, Gerasimos, Funck-Brentano, Christian, Hobbs, Richard, Kearney, Peter, McDonagh, Theresa, Popescu, Bogdan A, Reiner, Zeljko, Sechtem, Udo, Sirnes, Per Anton, Tendera, Michal, Vardas Panos, E, Widimsky, Petr, EACTS Clinical Guidelines, Committee, Alfieri, Ottavio, Dunning, Joel, Elia, Stefano, Kappetein, Pieter, Lockowandt, Ulf, Sarris, George, Vouhe, Pascal, von Segesser, Ludwig, Agewall, Stefan, Aladashvili, Alexander, Alexopoulos, Dimitrios, Antunes, Manuel J, Atalar, Enver, Brutel de la Riviere, Aart, Doganov, Alexander, Eha, Jaan, Fajadet, Jean, Ferreira, Rafael, Garot, Jerome, Halcox, Julian, Hasin, Yonathan, Janssens, Stefan, Kervinen, Kari, Laufer, Gunther, Legrand, Victor, Nashef Samer, A M, Neumann, Franz-Josef, Niemela, Kari, Nihoyannopoulos, Petros, Noc, Marko, Piek, Jan J, Pirk, Jan, Rozenman, Yoseph, Sabate, Manel, Starc, Radovan, Thielmann, Matthias, Wheatley, David J, Windecker, Stephan, and Zembala, Marian
Subjects: myocardial, revascularization, medicine.medical_specialty, business.industry, Judgement, Medizin, MEDLINE, Conflict of interest, EuroSCORE, Evidence-based medicine, medicine.disease, Coronary artery bypass surgery, Cardiothoracic surgery, Internal medicine, medicine, Cardiology, Medical emergency, Cardiology and Cardiovascular Medicine, Risk assessment, business
Abstract: Guidelines and Expert Consensus Documents summarize and evaluate all available evidence with the aim of assisting physicians in selecting the best management strategy for an individual patient suffering from a given condition, taking into account the impact on outcome and the risk–benefit ratio of diagnostic or therapeutic means. Guidelines are no substitutes for textbooks and their legal implications have been discussed previously. Guidelines and recommendations should help physicians to make decisions in their daily practice. However, the ultimate judgement regarding the care of an individual patient must be made by his/her responsible physician(s). The recommendations for formulating and issuing ESC Guidelines and Expert Consensus Documents can be found on the ESC website (http://www.escardio.org/knowledge/guidelines/rules). Members of this Task Force were selected by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) to represent all physicians involved with the medical and surgical care of patients with coronary artery disease (CAD). A critical evaluation of diagnostic and therapeutic procedures is performed including assessment of the risk–benefit ratio. Estimates of expected health outcomes for society are included, where data exist. The level of evidence and the strength of recommendation of particular treatment options are weighed and graded according to predefined scales, as outlined in Tables 1 and 2 . View this table: Table 1 Classes of recommendations View this table: Table 2 Levels of evidence The members of the Task Force have provided disclosure statements of all relationships that might be perceived as real or potential sources of conflicts of interest. These disclosure forms are kept on file at European Heart House, headquarters of the ESC. Any changes in conflict of interest that arose during the writing period were notified to the ESC. The Task Force report received its entire financial support from the ESC and EACTS, without any involvement of the pharmaceutical, device, or surgical industry. ESC …
Published: 2010
Full Text: View/download PDF

30. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)

Author: European Association for Percutaneous Cardiovascular Interventions, Wijns, W, Kolh, P, Danchin, N, Di Mario, C, Falk, V, Folliguet, T, Garg, S, Huber, K, James, S, Knuuti, J, Lopez Sendon, J, Marco, J, Menicanti, L, Ostojic, M, Piepoli, M, Pirlet, C, Pomar, J, Reifart, N, Ribichini, F, Schalij, M, Sergeant, P, Serruys, P, Silber, S, Sousa, U, Taggart, M, D, ESC Committee for Practice Guidelines, Vahanian, A, Auricchio, A, Bax, J, Ceconi, C, Dean, V, Filippatos, G, Funck Brentano, C, Hobbs, R, Kearney, P, Mcdonagh, T, Popescu, B, Reiner, Z, Sechtem, U, Sirnes, P, Tendera, M, Vardas, P, Widimsky, P, EACTS Clinical Guidelines Committee, Alfieri, O, Dunning, J, Elia, S, Kappetein, P, Lockowandt, U, Sarris, G, Vouhe, P, von Segesser, L, Agewall, S, Aladashvili, A, Alexopoulos, D, Antunes, M, Atalar, E, Brutel de la Riviere, A, Doganov, A, Eha, J, Fajadet, J, Ferreira, R, Garot, J, Halcox, J, Hasin, Y, Janssens, S, Kervinen, K, Laufer, G, Legrand, V, Nashef, S, Neumann, F, Niemela, K, Nihoyannopoulos, P, Noc, M, Piek, J, Pirk, J, Rozenman, Y, Sabate, M, Starc, R, Thielmann, M, Wheatley, D, Windecker, S, Zembala, M, Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology, 2010, Teafctsurgeryehj, and 31:2501, 55i98
Subjects: myocardial revascularization, Settore MED/21 - Chirurgia Toracica
Published: 2010

31. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC)

Author: Task Force on the Prevention, Diagnosis, Treatment of Infective Endocarditis of the European Society of Cardiology, European Society of Clinical Microbiology, Infectious, Diseases, International Society of Chemotherapy for Infection, Cancer, Habib, G, Hoen, B, Tornos, P, Thuny, F, Prendergast, B, Vilacosta, I, Moreillon, P, de Jesus Antunes, M, Thilen, U, Lekakis, J, Lengyel, M, Müller, L, Naber, Ck, Nihoyannopoulos, P, Moritz, A, Zamorano, Jl, ESC Committee for Practice Guidelines, Vahanian, A, Auricchio, A, Bax, J, Ceconi, Claudio, Dean, V, Filippatos, G, Funck Brentano, C, Hobbs, R, Kearney, P, Mcdonagh, T, Mcgregor, K, Popescu, Ba, Reiner, Z, Sechtem, U, Sirnes, Pa, Tendera, M, Vardas, P, and Widimsky, P.
Subjects: Eur Heart J. 2009 Oct, 30(19):2369-413. Epub 2009 Aug 27
Published: 2009

32. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)

Author: Authors/Task Force Members, Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G, ESC Committee for Practice Guidelines, Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck Brentano C, Hobbs R, Kearney P, McDonagh T, McGregor K, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas P, Widimsky P, Document Reviewers, Al Attar N, Andreotti F, Aschermann M, Asteggiano R, Benza R, Berger R, Bonnet D, Delcroix M, Howard L, Kitsiou AN, Lang I, Maggioni A, Nielsen Kudsk JE, Park M, Price S, Domenech MT, Vonk Noordegraaf A, Zamorano J.L., PERRONE FILARDI, PASQUALE, Authors/Task Force, Member, Galiè, N, Hoeper, Mm, Humbert, M, Torbicki, A, Vachiery, Jl, Barbera, Ja, Beghetti, M, Corris, P, Gaine, S, Gibbs, J, Gomez Sanchez, Ma, Jondeau, G, Klepetko, W, Opitz, C, Peacock, A, Rubin, L, Zellweger, M, Simonneau, G, ESC Committee for Practice, Guideline, Vahanian, A, Auricchio, A, Bax, J, Ceconi, C, Dean, V, Filippatos, G, Funck Brentano, C, Hobbs, R, Kearney, P, Mcdonagh, T, Mcgregor, K, Popescu, Ba, Reiner, Z, Sechtem, U, Sirnes, Pa, Tendera, M, Vardas, P, Widimsky, P, Document, Reviewer, Al Attar, N, Andreotti, F, Aschermann, M, Asteggiano, R, Benza, R, Berger, R, Bonnet, D, Delcroix, M, Howard, L, Kitsiou, An, Lang, I, Maggioni, A, Nielsen Kudsk, Je, Park, M, PERRONE FILARDI, Pasquale, Price, S, Domenech, Mt, Vonk Noordegraaf, A, Zamorano, J. L., Cardiovascular Centre (CVC), Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, and Simonneau G.
Subjects: medicine.medical_treatment, Diagnostic Techniques, Cardiovascular, Cardiovascular Agents/therapeutic use, Cardiovascular, Anoxia, Risk Factors, Biological Markers/blood, Hypoxia, Referral and Consultation, Heart Diseases/complications/diagnosis/therapy, media_common, Terminal Care, ddc:618, Exercise Tolerance, Pulmonary, Prognosis, Terminal Care/methods, Thromboembolism/complications/diagnosis/therapy, Hypertension, Cardiology, Cardiology and Cardiovascular Medicine, Algorithms, Lung Transplantation, medicine.medical_specialty, Hypertension, Pulmonary/*diagnosis/etiology/*therapy, Heart Diseases, media_common.quotation_subject, Hypertension, Pulmonary, MEDLINE, Pulmonary Veno-Occlusive Disease/complications/diagnosis/therapy, Internal medicine, Thromboembolism, Exercise Tolerance/physiology, medicine, Lung transplantation, Humans, Quality (business), Task force, business.industry, Conflict of interest, Cardiovascular Agents, Evidence-based medicine, Diagnostic Techniques, Clinical trial, Cardiovascular agent, Anoxia/complications/diagnosis/therapy, Pulmonary Veno-Occlusive Disease, business, Biomarkers
Abstract: Guidelines and Expert Consensus Documents summarize and evaluate all currently available evidence on a particular issue with the aim to assist physicians in selecting the best management strategies for a typical patient, suffering from a given condition, taking into account the impact on outcome, as well as the risk/benefit ratio of particular diagnostic or therapeutic means. Guidelines are no substitutes for textbooks. The legal implications of medical guidelines have been discussed previously. A great number of Guidelines and Expert Consensus Documents have been issued in recent years by the European Society of Cardiology (ESC) as well as by other societies and organizations. Because of the impact on clinical practice, quality criteria for development of guidelines have been established in order to make all decisions transparent to the user. The recommendations for formulating and issuing ESC Guidelines and Expert Consensus Documents can be found on the ESC website (http://www.escardio.org/knowledge/guidelines). In brief, experts in the field are selected and undertake a comprehensive review of the published evidence for management and/or prevention of a given condition. Unpublished clinical trial results are not taken into account. A critical evaluation of diagnostic and therapeutic procedures is performed including assessment of the risk/benefit ratio. Estimates of expected health outcomes for larger societies are included, where data exist. The level of evidence and the strength of recommendation of particular treatment options are weighed and graded according to predefined scales, as outlined in Tables 1 and 2 . View this table: Table 1 Classes of recommendations View this table: Table 2 Levels of evidence The experts of the writing panels have provided disclosure statements of all relationships they may have which might be perceived as real or potential sources of conflicts of interest. These disclosure forms are kept on file at the European Heart House, headquarters of the ESC. Any changes in conflict of interest that arise …
Published: 2009
Full Text: View/download PDF

33. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology

Author: Horstkotte, D, Follath, F, Gutschik, E, Lengyel, M, Oto, A, Pavie, A, Solersoler, J, Thiene, Gaetano, VON GRAEVENITZ, A, Priori, Sg, Garcia, Ma, Blanc, Jj, Budaj, A, Cowie, M, Dean, V, Deckers, J, FERNANDEZ BURGOS, E, Lekakis, J, Lindahl, B, Mazzotta, G, Morais, J, Smiseth, Oa, Vahanian, A, Delahaye, F, Parkhomenko, A, Filipatos, G, Aldershvile, J, Vardas, P, TASK FORCE MEMBERS ON INFECTIVE ENDOCARDITIS OF THE EUROPEAN SOCIETY OF CARDIOLOGY, and ESC COMMITTEE FOR PRACTICE GUIDELINES CPG
Published: 2004

34. 2014 ESC/ESA Guidelines on non-cardiac surgery : cardiovascular assessment and management : the Joint Task Force on non-cardiac surgery : cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).

Author: ESC Committee for Practice Guidelines, ESA Clinical Guidelines Committee, Kristensen, S. D., Knuuti, Juhani, Saraste, Antti, Anker, Stefan D., Bøtker, Hans Erik, Hert, Stefan de, Ford, Ian, Gonzalez-Juanatey, José Ramón, Gorenek, Bulent, Heyndrickx, Guy R., Hoeft, Andreas, Huber, Kurt, Iung, Bernard, Kjeldsen, Keld, Longrois, Dan, Lüscher, Thomas F. (Thomas Felix), Piérard, Luc A., Pocock, Stuart J., Price, Susanna, Roffi, Marco, Sirnes, Per Anton, Sousa-Uva, Miguel, Voudris, Vassilis A., Pibarot, Philippe, ESC Committee for Practice Guidelines, ESA Clinical Guidelines Committee, Kristensen, S. D., Knuuti, Juhani, Saraste, Antti, Anker, Stefan D., Bøtker, Hans Erik, Hert, Stefan de, Ford, Ian, Gonzalez-Juanatey, José Ramón, Gorenek, Bulent, Heyndrickx, Guy R., Hoeft, Andreas, Huber, Kurt, Iung, Bernard, Kjeldsen, Keld, Longrois, Dan, Lüscher, Thomas F. (Thomas Felix), Piérard, Luc A., Pocock, Stuart J., Price, Susanna, Roffi, Marco, Sirnes, Per Anton, Sousa-Uva, Miguel, Voudris, Vassilis A., and Pibarot, Philippe
Published: 2014

35. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Author: Galie, Nazzareno, Hoeper, Marius M., Humbert, Marc, Torbicki, Adam, Vachiery, Jean-Luc, Barberà, Joan Albert, Beghetti, Maurice, Corris, Paul A., Gaine, Sean, Gibbs, J Simon R, Gomez-Sanchez, Miguel Angel, Jondeau, Guillaume, Klepetko, Walter, Opitz, Christian, Peacock, Andrew J., Rubin, Lewis, Zellweger, Michael, Simonneau, Gerald, ESC Committee for Practice Guidelines (CPG), Galie, Nazzareno, Hoeper, Marius M., Humbert, Marc, Torbicki, Adam, Vachiery, Jean-Luc, Barberà, Joan Albert, Beghetti, Maurice, Corris, Paul A., Gaine, Sean, Gibbs, J Simon R, Gomez-Sanchez, Miguel Angel, Jondeau, Guillaume, Klepetko, Walter, Opitz, Christian, Peacock, Andrew J., Rubin, Lewis, Zellweger, Michael, Simonneau, Gerald, and ESC Committee for Practice Guidelines (CPG)
Abstract: Journal Article, Practice Guideline, info:eu-repo/semantics/published
Published: 2009

36. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the

Author: AuthorsTask Force Members, Vahanian, A., Alfieri, O., Andreotti, F., Antunes, M. J., Barón-Esquivias, G., Baumgartner, H., Borger, M. A., Carrel, T. P., Bonis, M., Evangelista, A., Falk, V., Lung, B., Lancellotti, P., Pierard, L., Price, S., Schäfers, H. J., Schuler, G., Stepinska, J., Swedberg, K., Takkenberg, J., Oppell, U. O., Windecker, S., Zamorano, J. L., Zembala, M., Esc, Committee For Practice Guidelines, Bax, J. J., Ceconi, C., Dean, V., Deaton, C., Fagard, R., Funck-Brentano, C., Hasdai, D., Hoes, A., Kirchhof, P., Knuuti, J., Kolh, P., Mcdonagh, T., Moulin, C., Popescu, B. A., Reiner, Z., Sechtem, U., Sirnes, P. A., Tendera, M., Torbicki, A., Document Reviewers, Segesser, L., Badano, L. P., Bunc, M., Claeys, M. J., Drinkovic, N., Filippatos, G., Habib, G., Kappetein, A. P., Kassab, R., Lip, G. Y., Moat, N., Nickenig, G., Catherine Otto, Pepper, J., Piazza, N., Pieper, P. G., Rosenhek, R., Shuka, N., Schwammenthal, E., Schwitter, J., Mas, P. T., Trindade, P. T., Walther, T., Joint Task Force on the Management, Valvular Heart Disease, The European Society of Cardiology (ESC), and European Association for Cardio-Thoracic Surgery (EACTS)

37. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)

Author: Jl, Zamorano, Lancellotti P, Rodriguez Muñoz D, Victor Aboyans, Asteggiano R, Galderisi M, Habib G, Dj, Lenihan, Gy, Lip, Ar, Lyon, Lopez Fernandez T, Mohty D, Mf, Piepoli, Tamargo J, Torbicki A, Tm, Suter, Authors/Task Force Members, and Esc, Committee For Practice Guidelines

38. The European Society of Cardiology Clinical Practice Guidelines.

Author: Windecker S
Published: 2017
Full Text: View/download PDF

Catalog

Books, media, physical & digital resources

See catalog results

Searchworks

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources

Refine your results

38 results on '"ESC Committee, for Practice Guidelines"'

1. Corrigendum to '2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk' [Atherosclerosis 290 (2019) 140-205]

2. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes

3. 2019 ESC/EAS guidelines for the management of dyslipidaemias : Lipid modification to reduce cardiovascular risk

4. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes

5. Corrigendum to “2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk” (Atherosclerosis (2019) 290 (140–205), (S0021915019314595), (10.1016/j.atherosclerosis.2019.08.014))

6. Questions and Answers on Diagnosis and Management of Patients with Peripheral Arterial Diseases: A Companion Document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)

7. Questions and Answers on Diagnosis and Management of Patients with Peripheral Arterial Diseases: A Companion Document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)

8. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

9. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

10. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

11. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)

12. Third universal definition of myocardial infarction

13. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association

14. Guidelines for the management of atrial fibrillation The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

15. ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

16. ESC Guidelines on the management of cardiovascular diseases during pregnancy

17. Guidelines for the diagnosis and management of syncope (version 2009): the Task Force for the diagnosis and management of syncope of the European Society of Cardiology (ESC)

18. 2014 ESC/ESA Guidelines on non-cardiac surgery : cardiovascular assessment and management : the Joint Task Force on non-cardiac surgery : cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).

20. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation * Developed with the special contribution of the European Heart Rhythm Association

21. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)

22. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

23. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation * Developed with the special contribution of the European Heart Rhythm Association

25. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)

26. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

27. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC)

29. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)

30. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)

31. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC)

33. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology

34. 2014 ESC/ESA Guidelines on non-cardiac surgery : cardiovascular assessment and management : the Joint Task Force on non-cardiac surgery : cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).

36. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the

37. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)

38. The European Society of Cardiology Clinical Practice Guidelines.

Catalog

Searchworks

Select search scope, currently: Articles Catalog books, media & more in Jio Institute collections Articles journal articles & other e-resources

Search

Search Constraints

Refine your results

Search Limiters

Topic

Publication Year Range

Language

Publication Type

Journal

Database

Publisher

38 results on '"ESC Committee, for Practice Guidelines"'

Search Results

Catalog

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources